Days At A Glance Speakers Session Type Search
Type

    09:00 - 17:00 
    Pre-congress Courses
    12:00 - 20:00 
    REGISTRATION
    17:00 - 17:45 
    ECE 2019 Opening Ceremony
    L'Amphithéâtre
    17:45 - 18:15 
    Plenary: Geoffrey Harris Award Lecture
    L'Amphithéâtre
    Chairs: AJ van der Lely (The Netherlands) & Monica Marazuela (Spain)
    GH1
    Plenary: Geoffrey Harris Award Lecture
    Translational research in pituitary disease
    18:20 - 18:50 
    Plenary: European Journal of Endocrinology Award Lecture
    L'Amphithéâtre
    Chairs: Wiebke Arlt (UK) & AJ van der Lely (The Netherlands)
    EJE1
    Plenary: European Journal of Endocrinology Award Lecture
    New approaches in the differential diagnosis of Diabetes insipidus
    Basel, Switzerland
    19:00 - 19:30 
    Plenary 1
    L'Amphithéâtre
    Chairs: Marta Korbonits (UK) & Sebastian Neggers (The Netherlands)
    PL1
    Plenary 1
    Designing Cities and Homes as Exercise Machines: Helping endocrinologists to fight metabolic disease
    19:30 - 20:45 
    Welcome Reception
    Exhibition area

    07:00 - 18:00 
    REGISTRATION
    08:00 - 08:40 
    Meet The Expert 1: Diabetes, Obesity and Metabolism
    Forum 3
    Diabetes, Obesity and Metabolism
    MTE1
    Meet The Expert 1: Diabetes, Obesity and Metabolism
    The road from flash and continuous glucose monitoring towards closed loop systems in diabetes
    08:00 - 08:40 
    Meet The Expert 2: Diabetes, Obesity and Metabolism
    Auditorium Lumière
    Diabetes, Obesity and Metabolism
    MTE2
    Meet The Expert 2: Diabetes, Obesity and Metabolism
    Long-term endocrine-metabolic effects of bariatric surgery: do the benefits really outweigh the risks?
    08:00 - 08:40 
    Meet The Expert 3: Adrenal and Neuroendocrine Tumours
    Forum 2
    Adrenal and Neuroendocrine Tumours
    MTE3
    Meet The Expert 3: Adrenal and Neuroendocrine Tumours
    The management of primary aldosteronism
    08:00 - 08:40 
    Meet The Expert 4: Adrenal and Neuroendocrine Tumours
    Salle Gratte-Ciel 1+2+3
    Adrenal and Neuroendocrine Tumours
    MTE4
    Meet The Expert 4: Adrenal and Neuroendocrine Tumours
    Management of a life-long disease in CAH
    Munich, Germany
    08:00 - 08:40 
    Meet The Expert 5: Thyroid
    L'Amphithéâtre
    Thyroid
    MTE5
    Meet The Expert 5: Thyroid
    Risk classification of thyroid nodules by ultrasound and indications for FNA
    08:00 - 08:40 
    Meet The Basic Scientist 1: Interdisciplinary Endocrinology
    Forum 1
    Interdisciplinary Endocrinology
    MTBS1
    Meet The Basic Scientist 1: Interdisciplinary Endocrinology
    New tracers for PET in humans and rodents: Hopes, aims and current evidence
    08:00 - 08:45 
    Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
    Salon Prestige Gratte Ciel
    Chairs: AJ van der Lely (The Netherlands) & Andrea Giustina (Italy)
    PEM1
    PEM1.1
    Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
    Introduction: Why Policy and Advocacy matters, also to endocrinology - Includes methodology, response, demographics
    PEM1.2
    Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
    The clinical view of Endocrinology in Europe
    France
    PEM1.3
    Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
    The research view of Endocrinology in Europe
    Zürich, Switzerland
    PEM1.4
    Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
    The early-career perspective
    PEM1.5
    Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
    Closing remarks and discussion
    08:50 - 09:20 
    Interview with the ESE President and President-Elect
    L'Amphithéâtre
    09:20 - 09:50 
    Plenary 2
    ENDORSED BY: EJE (European Journal of Endocrinology)
    L'Amphithéâtre
    Chairs: Manuel Tena-Sempere (Spain) & Csilla Krausz (Italy)
    PL2
    PL2
    Plenary 2
    Genetic epidemiology of puberty timing and reproductive lifespan
    Cambridge, United Kingdom
    09:50 - 10:20 
    Tea & Coffee
    Exhibition area
    10:20 - 11:50 
    Symposium 1: Thyroid in cancer
    Forum 3
    Chairs: Barbara Jarzab (Poland) & Sophie Leboulleux (France)
    Thyroid
    S1.1
    Symposium 1: Thyroid in cancer
    What is the value of molecular markers in nodules
    S1.2
    Symposium 1: Thyroid in cancer
    Iodine refractoriness in thyroid cells
    Birmingham, UK
    S1.3
    Symposium 1: Thyroid in cancer
    New paradigms in the treatment of low risk thyroid cancer
    10:20 - 11:50 
    Symposium 2: Trends in Puberty
    Forum 2
    Chairs: Carlo Acerini (UK) & Vincent Prevot (France)
    Reproductive Endocrinology
    S2.1
    Symposium 2: Trends in Puberty
    Exploring the Epigenetic Landscape of Puberty
    S2.2
    Symposium 2: Trends in Puberty
    Endocrine disruptors in puberty
    Liège, Belgium
    S2.3
    Symposium 2: Trends in Puberty
    Genetic basis in puberty
    London, UK
    10:20 - 11:50 
    Symposium 3: Circadian clocks: from pathophysiology to chronomedicine
    Salle Gratte-Ciel 1+2+3
    Chairs: Ashley Grossman (UK) & Gudmundur Johannsson (Sweden)
    Interdisciplinary Endocrinology
    S3.1
    Symposium 3: Circadian clocks: from pathophysiology to chronomedicine
    Circadian control of glucocorticoid function
    Manchester, UK
    S3.2
    Symposium 3: Circadian clocks: from pathophysiology to chronomedicine
    Fixing the Broken Clock in Adrenal Disorders
    Sapienza University of Rome, Italy
    S3.3
    Symposium 3: Circadian clocks: from pathophysiology to chronomedicine
    Light Up Your Sex Life!
    10:20 - 11:50 
    Symposium 4: Immunology and endocrinology
    ENDORSED BY: EC (Endocrine Connections)
    Forum 1
    Chairs: Sandra Pekic (Serbia) & Simon Pearce (UK)
    Interdisciplinary Endocrinology
    S4.2
    Symposium 4: Immunology and endocrinology
    Clinical: Immunotherapy and endocrine disease
    S4.3
    Symposium 4: Immunology and endocrinology
    Transitional: The diagnostic value of autoimmune antibodies in endocrine disorders
    Stockholm, Sweden
    S4.1
    Symposium 4: Immunology and endocrinology
    Basic: Immunotherapy and endocrine disease
    10:20 - 11:50 
    Symposium 5: Microbiota as new treatment for diabetes and metabolic disease
    L'Amphithéâtre
    Chairs: Anton Luger (Austria) & Ioannis Androulakis (Greece)
    Diabetes, Obesity and Metabolism
    S5.1
    Symposium 5: Microbiota as new treatment for diabetes and metabolic disease
    Human gut microbiome: hopes, threats and promises
    S5.2
    Symposium 5: Microbiota as new treatment for diabetes and metabolic disease
    Fecal transplantation: Myth or reality
    S5.3
    Symposium 5: Microbiota as new treatment for diabetes and metabolic disease
    Targeted Microbiome Intervention for handling insulin resistance
    10:20 - 11:50 
    Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - OK, so that’s why; more insight into the ins and outs of obesity - 4th Joint Global Symposium on Obesity
    Auditorium Lumière
    Chairs: AJ van der Lely (The Netherlands) & Jenny Visser (The Netherlands) & Andre Lacroix (Canada)
    SS1.1
    Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - OK, so that’s why; more insight into the ins and outs of obesity - 4th Joint Global Symposium on Obesity
    Obesity gives you cancer: the bigger picture!
    SS1.2
    Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - OK, so that’s why; more insight into the ins and outs of obesity - 4th Joint Global Symposium on Obesity
    Sleep Deficiency: A Pathway to Obesity
    SS1.3
    Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - OK, so that’s why; more insight into the ins and outs of obesity - 4th Joint Global Symposium on Obesity
    Social economic impact of the globesity pandemic
    10:20 - 11:50 
    Nurses Session 1: Immuno-oncology (IO) meets Endocrinology
    Salon Prestige Gratte-Ciel
    Chairs: Niki Karavitaki (UK) & Chona Feliciano (UK)
    NS1.1
    Nurses Session 1: Immuno-oncology (IO) meets Endocrinology
    Overview of Immunotherapy: Indications and adverse effects
    NS1.2
    Nurses Session 1: Immuno-oncology (IO) meets Endocrinology
    Immunotherapy-induced Endocrinopathies: Assessment, Management and Monitoring
    London, UK
    NS1.3
    Nurses Session 1: Immuno-oncology (IO) meets Endocrinology
    The Role of the Endocrine Nurse in Managing Patients with Immunotherapy-induced Endocrinopathies
    Birmingham, UK
    12:00 - 13:00 
    Controversies Session: Food addiction in humans: to be or not to be?
    L'Amphithéâtre
    Chairs: Uberto Pagotto (Italy) & Gatta-Cherifi Blandine (France)
    Interdisciplinary Endocrinology
    C1.1
    Controversies Session: Food addiction in humans: to be or not to be?
    Food addiction in humans: to be or not to be?
    12:00 - 13:00 
    ESE Council of Affiliated Societies Session
    Auditorium Lumiere
    Chairs: Djuro Macut (Serbia) & Bulent Yildiz (Turkey)
    ECAS1.1
    ESE Council of Affiliated Societies Session
    Mapping Endocrinology in Europe - ECAS report
    ECAS1.2
    ESE Council of Affiliated Societies Session
    Centres of special interest - how could we move on?
    ECAS1.3
    ESE Council of Affiliated Societies Session
    3rd Early Career Clinical Endocrinologist session at EndoBridge 2019 - referring of a patient from primary care to the endocrinology unit
    12:00 - 13:00 
    Oral Communications 1: Calcium and Bone
    Salle Gratte-Ciel 1+2+3
    Chairs: Lars Rejnmark (Denmark) & Peter Kamenicky (France)
    OC1
    OC1.1
    Oral Communications 1: Calcium and Bone
    Genetic testing for hereditary hyperparathyroidism in a large UK cohort
    Cambridge, United Kingdom
    OC1.2
    Oral Communications 1: Calcium and Bone
    Urinary magnesium as predictor of nephrolithiasis in patients with asymptomatic primary hyperparathyroidism
    OC1.3
    Oral Communications 1: Calcium and Bone
    MENIN AND EZH2 ACTIVITIES MODULATE THE EXPRESSION OF THE LONG NON-CODING RNA HAR1B IN PARATHYROID TUMORS
    OC1.4
    Oral Communications 1: Calcium and Bone
    Risk of Sepsis, Respiratory Infections, and Kidney or Other Genitourinary (GU) Infections in Patients with Chronic Hypoparathyroidism (HypoPT): A Retrospective Cohort Study
    OC1.5
    Oral Communications 1: Calcium and Bone
    Renal Function in 711 patients with Hypoparathyroidism during more than 4 years of therapy
    12:00 - 13:00 
    Nurses Session 2: Meet the Nurse Expert
    Salon Prestige Gratte-Ciel
    Chairs: Sherwin Criseno (UK) & Janina Sauerwald (Germany)
    MTNE1
    Nurses Session 2: Meet the Nurse Expert
    Nursing Approach To The Holistic Care of Patients with Intellectual Disability
    12:00 - 13:00 
    Oral Communications 2: Diabetes 1
    Forum 2
    Chairs: Hubert Vidal (France) & Bruno Verges (France)
    OC2.1
    Oral Communications 2: Diabetes 1
    EVERY FIFTH PATIENT WITH TYPE 1 DIABETES SUFFERS FROM AN ADDITIONAL ENDOCRINOLOGICAL AUTOIMMUNE DISEASE – A FINNISH NATIONWIDE STUDY
    OC2.2
    Oral Communications 2: Diabetes 1
    Elevated glucose uptake in skeletal muscle with increased sarcolemma translocation of GLUT4 and glycogen synthesis contributes to bariatric surgery mediated diabetes remission
    OC2.3
    Oral Communications 2: Diabetes 1
    Identification of oxygen-18 isotope of breath carbon dioxide as a non-invasive marker to distinguish type 1 and type 2 diabetes
    OC2.4
    Oral Communications 2: Diabetes 1
    Empagliflozin attenuates the progression of atherosclerosis in APO-E knockout mice
    OC2.5
    Oral Communications 2: Diabetes 1
    5β-reductase (AKR1D1) deletion drives hepatic inflammation, fibrosis and tumour development in vitro and in vivo
    12:00 - 13:00 
    Oral Communications 3: Cushing's and acromegaly
    Forum 1
    Chairs: Ansgar Heck (Norway) & Marianne Andersen (Denmark)
    OC3.1
    Oral Communications 3: Cushing's and acromegaly
    Osilodrostat provides clinical benefit over 48 weeks in patients with Cushing disease: Results from the LINC 3 study
    OC3.2
    Oral Communications 3: Cushing's and acromegaly
    Outcomes after primary treatment for Nelson’s syndrome: a study from 13 UK centres
    Birmingham, UK
    OC3.3
    Oral Communications 3: Cushing's and acromegaly
    Monosynaptic inputs to corticotropin-releasing hormone neuron in hypothalamic paraventricular nucleus of mice at the whole brain scale
    OC3.4
    Oral Communications 3: Cushing's and acromegaly
    Restoration of basal glucose turnover after disease control in acromegaly depends on treatment modality: a prospective, investigator-initiated trial
    OC3.5
    Oral Communications 3: Cushing's and acromegaly
    T2-signal intensity, SST receptor expression and first-generation somatostatin analogues efficacy predict hormone and tumor responses to pasireotide in acromegaly
    12:00 - 13:00 
    Oral Communications 4: Thyroid 2
    Forum 3
    Chairs: Bernard Goichot (France) & James Hennessey (USA)
    OC4.1
    Oral Communications 4: Thyroid 2
    Subclinical hypothyroidism throughout pregnancy in TPOAb positive pregnant women
    OC4.2
    Oral Communications 4: Thyroid 2
    Thyroid Dysfunction And Mortality In Cardiovascular Hospitalized Patients – A 12 year Follow-up Observational Study
    OC4.3
    Oral Communications 4: Thyroid 2
    PROGNOSTIC IMPACT OF MICROSCOPIC EXTRATHYROIDAL EXTENSION (mETE) ON RECURRENCE-FREE SURVIVAL IN PATIENTS WITH PAPILLARY THYROID CARCINOMA (PTC)
    OC4.4
    Oral Communications 4: Thyroid 2
    Cardiac and vascular characteristics of thyroid hormone resistance syndrome in France
    OC4.5
    Oral Communications 4: Thyroid 2
    A comprehensive assessment of the interplay between the thyroid function and the immune system: results from the Human Functional Genomics Project
    13:00 - 15:00 
    Lunch & Poster viewing
    Exhibition area
    13:00 - 13:45 
    Nurses Textbook Launch, Lunch and Informal Networking
    ECE Hub
    13:45 - 14:45 
    Industry Sponsored Satellite Symposium
    Forum 2
    13:45 - 14:45 
    Industry Sponsored Satellite Symposium
    Forum 1
    13:45 - 14:45 
    Industry Sponsored Satellite Symposium
    Salle Gratte-Ciel 1+2+3
    14:00 - 14:45 
    New Scientific Approach 1
    Forum 3
    Chair: Matti Poutanen (Finland)
    NSA1
    New Scientific Approach 1
    Steroidomics
    Giessen, Germany
    14:00 - 14:45 
    New Scientific Approach 2
    Auditorium Lumière
    Chair: Agnieszka Piekielko-Witkowska (Poland)
    NSA2
    New Scientific Approach 2
    Single cell spatial reconstruction of endocrine organs
    15:00 - 16:30 
    Symposium 6: A better life with thyroid hormone
    ENDORSED BY: EJE (European Journal of Endocrinology)
    L'Amphithéâtre
    Chairs: Emese Mezosi (Hungary) & Ulla Feldt-Rasmussen (Denmark)
    Thyroid
    S6.1
    Symposium 6: A better life with thyroid hormone
    Prediction of the thyroid axis set-point
    S6.2
    Symposium 6: A better life with thyroid hormone
    Subclinical hypothyroidism in children
    S6.3
    Symposium 6: A better life with thyroid hormone
    Subclinical hypothyroidism in the elderly
    Newcastle, UK
    15:00 - 16:30 
    Symposium 7: Endocrine Disrupting Chemicals
    ENDORSED BY: EC (Endocrine Connections)
    Forum 3
    Chairs: Josef Koehrle (Germany) & Anne-Simone Parent (Belgium)
    Environmental, Society and Governance
    S7.1
    Symposium 7: Endocrine Disrupting Chemicals
    Endocrine Disrupting Chemicals and Thyroid
    S7.2
    Symposium 7: Endocrine Disrupting Chemicals
    Endocrine Disrupting Chemicals and Diabetes Mellitus
    S7.3
    Symposium 7: Endocrine Disrupting Chemicals
    Endocrine Disrupting Chemicals and Obesity
    15:00 - 16:30 
    Symposium 8: Gender dysphoria
    Salle Gratte-Ciel 1+2+3
    Chairs: Feyza Darendeliler (Turkey) & Luca Persani (Italy)
    Interdisciplinary Endocrinology
    S8.1
    Symposium 8: Gender dysphoria
    Psychoendocrinology Of Gender Dysphoria
    S8.2
    Symposium 8: Gender dysphoria
    Gender Dysphoria –management of puberty
    Ghent, Belgium
    S8.3
    Symposium 8: Gender dysphoria
    Gender reassignment surgery in dysphoria
    15:00 - 16:30 
    Symposium 9: Controversies in adrenal disease
    Forum 2
    Chairs: Judith Favier (France) & Daniel Olsson (Sweden)
    Adrenal and Neuroendocrine Tumours
    S9.3
    Symposium 9: Controversies in adrenal disease
    Is there a role for subtotal adrenalectomy
    S9.1
    Symposium 9: Controversies in adrenal disease
    Metanephrines - plasma or urine?
    Dresden , Germany
    S9.2
    Symposium 9: Controversies in adrenal disease
    The do's and don'ts of genetic testing in phaeochromocytoma
    15:00 - 16:30 
    Symposium 10: Cancer drug-induced osteoporosis
    ENDORSED BY: EC (Endocrine Connections)
    Forum 1
    Chairs: Martine Cohen-Solal (France) & Carola Zillikens (The Netherlands)
    Calcium and Bone
    S10.1
    Symposium 10: Cancer drug-induced osteoporosis
    Mechanisms of skeletal metastasis (could be induced by breast cancer or prostate cancer or both)
    Dresden, Germany
    S10.2
    Symposium 10: Cancer drug-induced osteoporosis
    Aromatase inhibitors and bone
    S10.3
    Symposium 10: Cancer drug-induced osteoporosis
    TSH-suppressive therapy and bone
    15:00 - 17:00 
    Nurses Session 3: Professional Development
    Salon Prestige Gratte-Ciel
    Chairs: Sofia Llahana (UK) & Sherwin Criseno (UK)
    NPD1.1
    Nurses Session 3: Professional Development
    Update from the ESE Nurses Working Group, future projects and presentation of Poster Awards
    London, UK
    NPD1.2
    Nurses Session 3: Professional Development
    2018 Poster Award Presentation: Testosterone replacement: 'The best practice' and the role of the Endocrine Nurse
    London, UK
    NPD1.5
    Nurses Session 3: Professional Development
    Parallel Workshops - How to use the Textbook in Advanced Endocrine Nursing and Competency Framework to develop your clinical practice (Acromegaly)
    USA), Lisa Shepherd
    NDP1.4
    Nurses Session 3: Professional Development
    Parallel Workshops - MY DIABBY – Improving skills and competence in diabetes education
    NPD1.3
    Nurses Session 3: Professional Development
    Parallel Workshops - How to use the Textbook in Advanced Endocrine Nursing and Competency Framework to develop your clinical practice (Adrenal Insufficiency)
    London, UK
    15:15 - 16:30 
    Debate 1: Surgical treatment of phaeochromocytoma - query pre-treatment?
    Auditorium Lumière
    Chairs: Massimo Mannelli (Italy) & Frederic Castinetti (France)
    Adrenal and Neuroendocrine Tumours
    D1.1
    Debate 1: Surgical treatment of phaeochromocytoma - query pre-treatment?
    FOR: Surgical treatment of phaeochromocytoma - query pre-treatment?
    Nijmegen, The Netherlands
    D1.2
    Debate 1: Surgical treatment of phaeochromocytoma - query pre-treatment?
    AGAINST: Surgical treatment of phaeochromocytoma - query pre-treatment?
    Essen, Germany
    16:30 - 17:00 
    Tea & Coffee
    Exhibition area
    17:00 - 17:30 
    Plenary 3
    L'Amphithéâtre
    Chairs: Bulent Yildiz (Turkey) & Anton Luger (Austria)
    PL3
    Plenary 3
    Pancreatic beta-cell ageing: Novel mechanisms and consequences in the management of diabetes
    17:45 - 19:15 
    Industry Sponsored Satellite Symposium
    Forum 1
    17:45 - 19:15 
    Industry Sponsored Satellite Symposium
    Forum 2
    17:45 - 19:15 
    Industry Sponsored Satellite Symposium
    Salle Gratte-Ciel 1+2+3
    19:30 - 23:00 
    Informal Networking Evening
    (Badge holders only)

    07:00 - 18:00 
    REGISTRATION
    08:00 - 08:40 
    Meet The Expert 6: Calcium and Bone
    Forum 3
    Calcium and Bone
    MTE6
    Meet The Expert 6: Calcium and Bone
    Primary Hyperparathyroidism: Surgical vs Medical Therapy
    08:00 - 08:40 
    Meet The Expert 7: Pituitary and Neuroendocrinology
    L'Amphithéâtre
    Pituitary and Neuroendocrinology
    MTE7
    Meet The Expert 7: Pituitary and Neuroendocrinology
    Non functional Pituitary Tumours - not always easy
    08:00 - 08:40 
    Meet The Expert 8: Reproductive Endocrinology
    Auditorium Lumière
    Reproductive Endocrinology
    MTE8
    Meet The Expert 8: Reproductive Endocrinology
    Co-morbidities in Turner syndrome
    08:00 - 08:40 
    Meet The Expert 9: Reproductive Endocrinology
    Forum 2
    Reproductive Endocrinology
    MTE9
    Meet The Expert 9: Reproductive Endocrinology
    Co-morbidities in Klinefelter syndrome
    08:00 - 08:40 
    Meet The Expert 10: Reproductive Endocrinology
    Forum 1
    Reproductive Endocrinology
    MTE10
    Meet The Expert 10: Reproductive Endocrinology
    NCAH and Female reproduction
    08:00 - 08:40 
    Meet The Basic Scientist 2
    Salle Gratte-Ciel 1+2+3
    MTBS2
    Meet The Basic Scientist 2
    Genetically tailored pig models in translational endocrine and metabolic research
    08:50 - 09:20 
    Plenary 4
    L'Amphithéâtre
    Chairs: Camilla Schalin-Jäntti (Finland) & Beata Kos-Kulda (Poland)
    PL4
    Plenary 4
    Exercise training in the management of T2D
    09:20 - 09:50 
    Plenary: European Hormone Medal Lecture
    L'Amphithéâtre
    Chairs: Djuro Macut (Serbia) & Andrea Giustina (Italy)
    EHM1
    Plenary: European Hormone Medal Lecture
    Monogenic Bone Disorders as a Model for Novel Treatment of Osteoporosis
    09:50 - 10:20 
    Tea & Coffee
    Exhibition area
    10:20 - 11:20 
    Debate 2: T4 is not enough
    L'Amphithéâtre
    Chairs: Robin Peeters (The Netherlands) & Patrice Rodien (France)
    Thyroid
    D2.2
    Debate 2: T4 is not enough
    AGAINST: No, T4 is enough
    D2.1
    Debate 2: T4 is not enough
    FOR: Yes, T4 is not enough
    10:20 - 11:50 
    Symposium 11: EDCs and reproduction
    Forum 3
    Chairs: Rachel Desailloud (France) & Anna-Maria Andersson (Denmark)
    Environmental, Society and Governance
    S11.1
    Symposium 11: EDCs and reproduction
    Oocytes, Pesticides and IVF
    S11.2
    Symposium 11: EDCs and reproduction
    Testicular germ cell cancer: role of fœtal exposure to endocrine disruptors
    S11.3
    Symposium 11: EDCs and reproduction
    Mitigating against endocrine disruption in pregnancy
    Copenhagen, Denmark
    10:20 - 11:50 
    Symposium 12: Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
    Forum 1
    Chairs: Michael Buchfelder (Germany) & Cesar Boguszewski (Brazil)
    Pituitary and Neuroendocrinology
    S12.1
    Symposium 12: Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
    The view of the surgeon: When, how much and when to refrain from surgery?
    S12.2
    Symposium 12: Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
    New potential treatment alternatives in patients with papillary craniopharyngioma
    S12.3
    Symposium 12: Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
    How to manage the long-term consequences of hypothalamic damages
    10:20 - 11:50 
    Symposium 13: Central Control of Metabolism: Brain rules all
    Salle Gratte-Ciel 1+2+3
    Chairs: Johannes Romijn (The Netherlands) & Ivana Kraljevic (Croatia)
    Diabetes, Obesity and Metabolism
    S13.1
    Symposium 13: Central Control of Metabolism: Brain rules all
    All optics in the metabolic brain
    S13.2
    Symposium 13: Central Control of Metabolism: Brain rules all
    Role of mitochondria/cell bioenergetics in CNS regulation of energy balance
    S13.3
    Symposium 13: Central Control of Metabolism: Brain rules all
    Genetics of appetite regulation
    Cambridge, UK
    10:20 - 11:50 
    Symposium 14: Innovations in NETs
    Auditorium Lumière
    Chairs: Diego Ferone (Italy) & Mehtap Cakir (Turkey)
    Adrenal and Neuroendocrine Tumours
    S14.1
    Symposium 14: Innovations in NETs
    Innovative imaging of insulinoma: The end of sampling…
    S14.2
    Symposium 14: Innovations in NETs
    A role for radionuclide therapy for high-grade NETs
    S14.3
    Symposium 14: Innovations in NETs
    Fishing for NETs
    10:20 - 11:50 
    Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
    Forum 2
    Chairs: Peter Aldiss (UK) & Thomas Cuny (France)
    Organ cross-talk in endocrine disease
    S15.1
    Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
    Welcome and Introduction to EYES
    S15.2
    Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
    Investigating glucocorticoids as the mechanism behind bone marrow adiposity expansion during caloric restriction
    S15.3
    Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
    Role of hypothalamic bile acid-TGR5 signaling in the regulation of energy balance
    S15.4
    Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
    The role and cross-talk between incretin hormones and occurrence of Nonalcoholic steatohepatitis
    S15.5
    Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
    Lysophosphatidic acid in pathogenesis of HNF1B-MODY syndrome
    S15.6
    Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
    Closing remarks
    10:20 - 12:05 
    Nurses Session 4: Parathyroid Disorders
    Salon Prestige Gratte-Ciel
    Chairs: Zaki Hassan-Smith (UK) & Maria Pedersen (Sweden)
    NPD2.1
    Nurses Session 4: Parathyroid Disorders
    Hypoparathyroidism: Aetiology, diagnosis and challenges in management
    NPD2.2
    Nurses Session 4: Parathyroid Disorders
    Hyperparathyroidism: Evidence-based screening and management
    Dublin, Ireland
    NPD2.3
    Nurses Session 4: Parathyroid Disorders
    Parathyroid Surgery: Indications and Consequences
    12:00 - 13:00 
    Debate 3: Pituitary Pathology: Do we care?
    L'Amphithéâtre
    Chairs: Gerald Raverot (France) & Jens Otto Jorgensen (Denmark)
    Pituitary and Neuroendocrinology
    D3.1
    Debate 3: Pituitary Pathology: Do we care?
    FOR: Yes, we care about pituitary pathology
    D3.2
    Debate 3: Pituitary Pathology: Do we care?
    AGAINST: No, we don't care about pituitary pathology
    12:00 - 13:00 
    Oral Communications 8: Reproduction 1
    Forum 1
    Chairs: Victor Navarro (USA) & Nadine Binart (France)
    OC8.1
    Oral Communications 8: Reproduction 1
    Dissecting the roles of KNDy-derived kisspeptins in the control of reproduction: Generation and characterization of the Tac2-specific Kiss1 KO (TaK-KO) mouse
    OC8.2
    Oral Communications 8: Reproduction 1
    AMH is a predictive factor for successful sperm retrieval in non-mosaic Klinefelter syndrome patients
    OC8.3
    Oral Communications 8: Reproduction 1
    Endocrine Disruptors transgenerationally alters pubertal timing through epigenetic reprogramming of the hypothalamus.
    OC8.4
    Oral Communications 8: Reproduction 1
    Conditional ablation of AMP-Activated Protein Kinase (AMPK) in GnRH Neurons Reveals Specific Roles in Reproductive and Metabolic Homeostasis
    OC8.5
    Oral Communications 8: Reproduction 1
    The Neurokinin 3 Receptor Antagonist, Fezolinetant, Is Effective in Treatment of Menopausal Vasomotor Symptoms: Responder Analysis Results From a Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Study
    12:00 - 13:00 
    Oral Communications 9: Thyroid 1
    Auditorium Lumière
    Chairs: Clara Alvarez (Spain) & Patrice Rodien (France)
    OC9.1
    Oral Communications 9: Thyroid 1
    3D mapping and in silico predictions of the DEHAL1 enzyme as a tool to discriminate pathogenic mutations from non-functional variants in hypothyroidism
    OC9.2
    Oral Communications 9: Thyroid 1
    Direct evidence for disulfides in the mechanism of deiodinase 1
    OC9.3
    Oral Communications 9: Thyroid 1
    Novel driver mutations in thyroid cancer recurrence
    Birmingham, United Kingdom
    OC9.4
    Oral Communications 9: Thyroid 1
    Resistance to thyroid hormone alpha associated with early-onset severe NASH
    OC9.5
    Oral Communications 9: Thyroid 1
    Deciphering the origin of the sexually dimorphic thyrotropin secretion in mouse models.
    12:00 - 13:00 
    Oral Communications 5: Adrenal 2
    Forum 3
    Chairs: Francoise Borson Chazot (France) & Felix Beuschlein (Switzerland)
    OC5.1
    Oral Communications 5: Adrenal 2
    Positive impact of genetic test on the management and outcome of patients with paraganglioma and/or pheochromocytoma
    OC5.2
    Oral Communications 5: Adrenal 2
    Pheochromocytoma aggressiveness induced by tumor microenvironment depends on the SDH subunit involved
    OC5.3
    Oral Communications 5: Adrenal 2
    SF3B1 as novel target for the treatment of multiple endocrine-related cancers
    OC5.4
    Oral Communications 5: Adrenal 2
    The splicing factor NOVA1 is overexpressed in pancreatic neuroendocrine tumors and related to increased aggressiveness and malignancy
    OC5.5
    Oral Communications 5: Adrenal 2
    Impact of adrenal insufficiency on patient-centred health care outcomes in adult medical inpatients
    12:00 - 13:00 
    Oral Communications 6: Obesity 1
    Forum 2
    Chairs: Giles Yeo (UK) & Blandine Gatta-Cherifi (France)
    OC6.1
    Oral Communications 6: Obesity 1
    Impaired Glucose Homeostasis in Leptin-Deficient ob/ob Mice is Corrected by AZP-3404, a 9-Amino Acid Peptide Analog Derived from Insulin-Like Growth Factor-Binding Protein 2, a Key Mediator of Leptin Action
    OC6.2
    Oral Communications 6: Obesity 1
    Deep Transcranial Magnetic Stimulation modulates body temperature in obesity
    OC6.3
    Oral Communications 6: Obesity 1
    Role of hypothalamic bile acid-TGR5 signaling in the regulation of energy balance
    OC6.4
    Oral Communications 6: Obesity 1
    Fat mass impact of Sirolimus after clinical islet transplantation, a case control study
    OC6.5
    Oral Communications 6: Obesity 1
    Lipolysis Defect in White Adipose Tissue and Rapid Weight Regaining
    12:00 - 13:00 
    Oral Communications 7: Endocrine Connections
    Salle Gratte-Ciel 1+2+3
    Chairs: Corin Badiu (Romania) & Marie-Christine Vantyghem (France)
    OC7.1
    Oral Communications 7: Endocrine Connections
    Cortisol suppression or peripheral sensitivity and activation are associated with diabetes, hypertension and fragility fractures in postmenopausal eucortisolemic women
    OC7.2
    Oral Communications 7: Endocrine Connections
    Thyroid hormones are new key regulators of glucocorticoid metabolism
    OC7.3
    Oral Communications 7: Endocrine Connections
    HIGHER DOSE OF BUROSUMAB IS NEEDED FOR TREATMENT OF CHILDREN WITH SEVER FORMS OF X-LINKED HYPOPHOSPHATEMIA
    OC7.4
    Oral Communications 7: Endocrine Connections
    Non-invasive detection of GNAS mutations causing McCune-Albright Syndrome with ddPCR on whole blood or circulating DNA.
    OC7.5
    Oral Communications 7: Endocrine Connections
    Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) syndrome : French prospective study in a cohort of 25 patients
    13:00 - 15:00 
    Lunch & Poster viewing
    Exhibition area
    13:00 - 14:00 
    ESE President meets new members
    13:00 - 14:00 
    Nurses Poster Viewing and Presentations, Lunch and Informal Networking
    Salon Prestige Gratte-Ciel
    13:00 - 13:45 
    Endo-ERN Session - Lunch Hub
    ECE Hub
    ERN1.1
    Endo-ERN Session - Lunch Hub
    Introduction and update on Endo-ERN
    ERN1.2
    Endo-ERN Session - Lunch Hub
    Core activities of Endo-ERN in close collaboration with ESE and ESPE: the multi-disciplinary approach
    ERN1.3
    Endo-ERN Session - Lunch Hub
    Core activities of Endo-ERN in close collaboration with ESE and ESPE: the multi-disciplinary approach
    13:45 - 14:45 
    Industry Sponsored Satellite Symposium
    Forum 2
    13:45 - 14:45 
    Industry Sponsored Satellite Symposium
    Forum 3
    13:45 - 14:45 
    Industry Sponsored Satellite Symposium
    Auditorium Lumière
    14:00 - 14:45 
    New Scientific Approach 3
    Salle Gratte-Ciel 1+2+3
    Chair: Guillaume Assie (France)
    NSA3
    New Scientific Approach 3
    Intelligent image based in situ single cell isolation
    14:00 - 14:45 
    New Scientific Approach 4
    Forum 1
    Chair: Vera Popovic (Serbia)
    NSA4
    New Scientific Approach 4
    When will AI take over from the endocrinologist?
    15:00 - 16:30 
    Symposium 16: Thyroid in pregnancy
    L'Amphithéâtre
    Chairs: Sophie Christin-Maitre (France) & Leonidas Duntas (Greece)
    Thyroid
    S16.1
    Symposium 16: Thyroid in pregnancy
    Thyroid autoimmunity and fertility
    S16.2
    Symposium 16: Thyroid in pregnancy
    Thyroid disease and pregnancy outcomes
    S16.3
    Symposium 16: Thyroid in pregnancy
    Thyroid disease and offspring development
    15:00 - 16:30 
    Symposium 17: Where Do Pituitary Tumours Come From
    Forum 1
    Chairs: Günter K. Stalla (Germany) & Philippe Chanson (France)
    Pituitary and Neuroendocrinology
    S17.1
    Symposium 17: Where Do Pituitary Tumours Come From
    Specification of cell fate
    Montreal, Canada
    S17.2
    Symposium 17: Where Do Pituitary Tumours Come From
    Pertubations in novel signalling pathways
    London, UK
    S17.3
    Symposium 17: Where Do Pituitary Tumours Come From
    From Lab to Clinic - Can we translate into effective therapeutics
    Paris, France
    15:00 - 16:30 
    Symposium 18: Congenital Hypogonadotropic Hypogonadism: New insights into GnRH Regulation
    Salle Gratte-Ciel 1+2+3
    Chairs: Ursula Kaiser (USA) & Nelly Pitteloud (Switzerland)
    Reproductive Endocrinology
    S18.1
    Symposium 18: Congenital Hypogonadotropic Hypogonadism: New insights into GnRH Regulation
    GnRH migration and vomeronasal neurons
    S18.2
    Symposium 18: Congenital Hypogonadotropic Hypogonadism: New insights into GnRH Regulation
    Flipping the GnRH switch with microRNAs
    S18.3
    Symposium 18: Congenital Hypogonadotropic Hypogonadism: New insights into GnRH Regulation
    Congenital Hypogonadotropic Hypogonadism: Clinical Perspectives
    15:00 - 16:30 
    Symposium 19: Adrenal Insufficiency
    Forum 2
    Chairs: Antoine Tabarin (France) & Thierry Brue (France)
    Adrenal and Neuroendocrine Tumours
    S19.1
    Symposium 19: Adrenal Insufficiency
    New insights into autoimmune adrenal insufficiency

    Unknown speaker

    Bergen, Norway
    S19.2
    Symposium 19: Adrenal Insufficiency
    Long-term results of slow acting glucocorticoids - are they really better?
    S19.3
    Symposium 19: Adrenal Insufficiency
    Optimising care delivery in Congenital Adrenal Hyperplasia
    Sheffield, UK
    15:00 - 16:30 
    Symposium 20: News on Nutrition: When to eat what
    Forum 3
    Chairs: Bruno Verges (France) & Justo Castaño (Spain)
    Diabetes, Obesity and Metabolism
    S20.1
    Symposium 20: News on Nutrition: When to eat what
    Precision Nutrition for managing obesity – Does it work?
    S20.2
    Symposium 20: News on Nutrition: When to eat what
    Is limiting the timing of food intake a viable nutritional approach?
    S20.3
    Symposium 20: News on Nutrition: When to eat what
    PREDIMED Plus trial - energy-restricted Mediterranean diet plus exercise and metabolic health
    15:00 - 16:30 
    Guidelines Session: ESE Clinical Practice Guidelines on the Endocrine Work-up in Obesity
    Auditorium Lumière
    Chair: Michel Pugeat (France)
    GS1
    Guidelines Session: ESE Clinical Practice Guidelines on the Endocrine Work-up in Obesity
    Topics: 'Hormonal alterations in obesity', 'Thyroid dysfunction', 'Hypercortisolism', 'Gonadal dysfunction' & 'cther hormones'
    16:50 - 17:20 
    Plenary: Clinical Endocrinology Trust Lecture
    L'Amphithéâtre
    Chairs: Jerome Bertherat (France) & Wiebke Arlt (UK)
    CET1
    Plenary: Clinical Endocrinology Trust Lecture
    How can patients perception of outcome be improved after controlling pituitary disease?
    Barcelona, Spain
    17:20 - 17:50 
    Plenary 5
    L'Amphithéâtre
    Chairs: Felix Beuschlein (Germany) & Françoise Borson-Chazot (France)
    PL5
    Plenary 5
    Paracrine regulation of the adrenal cortex
    18:00 - 19:30 
    Industry Sponsored Satellite Symposium
    Salle Gratte-Ciel 1+2+3

    07:00 - 17:30 
    REGISTRATION
    08:00 - 08:40 
    Meet The Expert 11: Calcium and Bone
    Forum 2
    Calcium and Bone
    MTE11
    Meet The Expert 11: Calcium and Bone
    Shifting treatment paradigms in osteoporosis
    08:00 - 08:40 
    Meet The Expert 12: Calcium and Bone
    Forum 1
    Calcium and Bone
    MTE12
    Meet The Expert 12: Calcium and Bone
    Fracture risk prediction in benign and tumoral bone: new insights
    08:00 - 08:40 
    Meet The Expert 13: Interdisciplinary Endocrinology
    Forum 3
    Interdisciplinary Endocrinology
    MTE13
    Meet The Expert 13: Interdisciplinary Endocrinology
    Flushing, blushing and sweating
    08:00 - 08:40 
    Meet The Expert 14: Interdisciplinary Endocrinology
    Salle Gratte-Ciel 1+2+3
    Interdisciplinary Endocrinology
    MTE14
    Meet The Expert 14: Interdisciplinary Endocrinology
    How multidisciplinary care and tailor-made transition save lives of young adults with Prader-Willi syndrome
    08:00 - 08:40 
    Meet The Expert 15: Pituitary and Neuroendocrinology
    L'Amphithéâtre
    Pituitary and Neuroendocrinology
    MTE15
    Meet The Expert 15: Pituitary and Neuroendocrinology
    To what degree does hypopituitarism exist after TBI?
    08:00 - 08:40 
    Meet The Expert 16: Interdisciplinary Endocrinology
    Auditorium Lumière
    Interdisciplinary Endocrinology
    MTE16.2
    Meet The Expert 16: Interdisciplinary Endocrinology
    Is it all in your head or just in the lab?
    MTE16.1
    Meet The Expert 16: Interdisciplinary Endocrinology
    Is it all in your head or just in the lab?
    08:00 - 08:40 
    Meet The Basic Scientist 3
    Salon Prestige Gratte-Ciel
    MTBS3
    Meet The Basic Scientist 3
    The “Gravitostat” – How does it relate to hormones?
    08:50 - 09:20 
    Plenary 6
    L'Amphithéâtre
    Chairs: Claudio Marcocci (Italy) & Jacque Orgiazzi (France)
    PL6
    Plenary 6
    Treatment strategies for Graves orbitopathy
    Mianz, Germany
    09:20 - 09:50 
    Tea & Coffee
    Exhibition area
    09:50 - 10:50 
    Debate 4: MicroRNAs as hormones?
    Salle Gratte-Ciel 1+2+3
    Chairs: Peter Igaz (Hungary) & Attila Patócs (Hungary)
    Interdisciplinary Endocrinology
    D4.2
    Debate 4: MicroRNAs as hormones?
    AGAINST: MicroRNAs as hormones?
    D4.1
    Debate 4: MicroRNAs as hormones?
    FOR: MicroRNAs and extracellular vesicles as hormones?
    09:50 - 11:20 
    Symposium 21: Rare Bone Disorders
    Forum 2
    Chairs: Barbara Obermayer-Pietsch (Austria) & Lars Rejmark (Denmark)
    Calcium and Bone
    S21.1
    Symposium 21: Rare Bone Disorders
    Animal model of bone fragility
    Pavia, Italy
    S21.2
    Symposium 21: Rare Bone Disorders
    New perspectives on the treatment of skeletal dysplasia
    Paris, France
    S21.3
    Symposium 21: Rare Bone Disorders
    Osteogenesis imperfecta throughout life
    Oxford, UK
    09:50 - 11:20 
    Symposium 22: The Pituitary As Metabolic Sensor
    Forum 1
    Chairs: Clara Alvarez (Spain) & Agnieszka Baranowska-Bik (Poland)
    Pituitary and Neuroendocrinology
    S22.1
    Symposium 22: The Pituitary As Metabolic Sensor
    Kiss1 as integrator of endocrine and metabolic function in the hypothalamic-pituitary axis
    S22.2
    Symposium 22: The Pituitary As Metabolic Sensor
    How treatments with endocrine & metabolic drugs influence pituitary cell function?
    S22.3
    Symposium 22: The Pituitary As Metabolic Sensor
    Bidirectional interrelationship between growth hormone and metabolism
    09:50 - 11:20 
    Symposium 23: PCOS: Can we personalise treatment?
    Auditorium Lumière
    Chairs: Marija Pfeifer (Slovenia) & Terhi Piltonen (Finland)
    Reproductive Endocrinology
    S23.1
    Symposium 23: PCOS: Can we personalise treatment?
    Gut brain axis
    S23.2
    Symposium 23: PCOS: Can we personalise treatment?
    Implicating androgen excess in metabolic disease in PCOS

    Unknown speaker

    S23.3
    Symposium 23: PCOS: Can we personalise treatment?
    Treatment options in cardiometabolic PCOS phenotype
    09:50 - 11:20 
    Symposium 24: What's new in the Adrenal Cortex?
    ENDORSED BY: EJE (European Journal of Endocrinology)
    Forum 3
    Chairs: Darko Kastelan (Croatia) & Marc Lombes (France)
    Adrenal and Neuroendocrine Tumours
    S24.1
    Symposium 24: What's new in the Adrenal Cortex?
    New genes, new understanding, new therapy
    S24.2
    Symposium 24: What's new in the Adrenal Cortex?
    Primary hyperaldosteronism: does our treatment work?
    S24.3
    Symposium 24: What's new in the Adrenal Cortex?
    Autonomous cortisol secretion has cardiovascular consequences
    09:50 - 11:20 
    Symposium 25: Late breaking
    L'Amphithéâtre
    Chairs: Sebastian Neggers (The Netherlands) & Manuel Tena-Sempere (Spain)
    S25.1
    Symposium 25: Late breaking
    Liver Stress kinases – crossroad between obesity and liver cancer (Source paper: Nature 2019)
    S25.2
    Symposium 25: Late breaking
    LT4 treatment and pregnancy outcomes in TPOab positive women: results of the TABLET Trial
    S25.3
    Symposium 25: Late breaking
    Maternal smoking and high BMI disrupt thyroid gland development
    09:50 - 11:20 
    Publishing Session
    Salon Prestige Gratte-Ciel
    Chair: Beata Kos-Kulda (Poland)
    PS1.1
    Publishing Session
    Endocrine Connections - ‘Increase the visibility of your research: open access and more’
    PS1.2
    Publishing Session
    EDM Case Reports - ‘Top tips for writing and submitting an article – an early career researcher’s perspective’
    PS1.3
    Publishing Session
    European Journal of Endocrinology - ‘Common methodological flaws and how to avoid them’
    11:30 - 12:30 
    Oral Communications 10: Adrenal 1
    Forum 2
    Chairs: Attila Patocs (Hungary) & Jerome Bertherat (France)
    OC10.1
    Oral Communications 10: Adrenal 1
    Steroid Metabolomics: A Rapid Computational Approach for Accurate Differentiation of Inborn Disorders of Steroidogenesis.
    OC10.2
    Oral Communications 10: Adrenal 1
    Glucocorticoid resistance patients exhibit defective cortisol metabolism, responsible for functional hypermineralocorticism
    OC10.3
    Oral Communications 10: Adrenal 1
    Genetic predisposition to Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH): next generation sequencing ARMC5, NR3C1 (Glucocorticoid Receptor) and PDE11A4 (Phosphodiesterase 11) in 389 patients
    OC10.4
    Oral Communications 10: Adrenal 1
    Cullin 3 is a partner of Armadillo Repeat Containing 5 (ARMC5), the product of the gene responsible for Primary Bilateral Macronodular Adrenal Hyperplasia
    OC10.5
    Oral Communications 10: Adrenal 1
    Cyclin Dependent Kinase 4 as promising drug target in adrenocortical carcinoma
    Birmingham, United Kingdom
    11:30 - 12:30 
    UEMS Session
    Forum 3
    Chairs: Maeve Durkan (Republic of Ireland) & Teri Brouwer (The Netherlands)
    UEMS1.2
    UEMS Session
    Update on European Exam in Endocrinology
    Waterford, Ireland
    UEMS1.1
    UEMS Session
    The role of UEMS in Europe and the distinct and independent but allied pathway with ESE
    UEMS1.3
    UEMS Session
    The microenvironment of pituitary neuroendocrine tumors: focus on folliculostellate cells
    11:30 - 12:30 
    Oral Communications 11: Diabetes 2
    Auditorium Lumière
    Chairs: Philippe Moulin (France) & Colin Duncan (UK)
    OC11.1
    Oral Communications 11: Diabetes 2
    Hormonal factors and type 2 diabetes risk in women: a 22 year follow-up study on more than 83 000 women from the E3N cohort study
    OC11.2
    Oral Communications 11: Diabetes 2
    Molecular Mechanisms Regulating Hepatic Sex Hormone-Binding Globulin Production. Clinical Implications in Human Diseases.
    OC11.3
    Oral Communications 11: Diabetes 2
    Implications of circulating Meteorin-like (Metrnl) level in human subjects with type 2 diabetes
    OC11.4
    Oral Communications 11: Diabetes 2
    MiR-30e-5p expression is downregulated in plasma and urine of type 1 diabetic patients with diabetic kidney disease
    OC11.5
    Oral Communications 11: Diabetes 2
    Bone metabolism and circulating myeloid calcifying cells in diabetic post menopausal women: a case-control study
    11:30 - 12:30 
    Oral Communications 12: Endocrine Connections 2
    Salle Gratte-Ciel 1+2+3
    Chairs: Patric Delhanty (The Netherlands) & Paolo Beck-Peccoz (Italy)
    OC12.1
    Oral Communications 12: Endocrine Connections 2
    Weekly shifts in light-dark cycle disrupt circadian clock gene expression in bone and reduce bone turnover
    OC12.2
    Oral Communications 12: Endocrine Connections 2
    Epigenetic Programming of Transgenerational Hypertension in Preterm Birth Mice
    OC12.3
    Oral Communications 12: Endocrine Connections 2
    Neuronostatin and GPR107 system: a novel therapeutic circuit in Prostate Cancer.
    OC12.4
    Oral Communications 12: Endocrine Connections 2
    Long-term follow-up of antitumoral immunotherapy- induced hypophysitis in Lille hospital, France
    OC12.5
    Oral Communications 12: Endocrine Connections 2
    Sexual desire in transgender persons in relation with gender affirming hormone treatment. Results from ENIGI, a large multicenter prospective cohort study in transgender people
    11:30 - 12:30 
    Oral Communcations 13: Anteria and posteria pituitary
    Forum 1
    Chairs: Mirjam Christ-Crain (Sweden) & Charlotte Højby (Sweden)
    OC13.1
    Oral Communcations 13: Anteria and posteria pituitary
    Arginine-stimulated Copeptin Measurements - A new Test for Diabetes Insipidus
    OC13.2
    Oral Communcations 13: Anteria and posteria pituitary
    Empagliflozin increases sodium-levels in patients with the syndrome of inappropriate antidiuretic hormone secretion – a randomized, double-blind, placebo-controlled trial
    OC13.3
    Oral Communcations 13: Anteria and posteria pituitary
    Pituitary tumour-derived chemokines modulate immune cell infiltrates in the tumour microenvironment leading to aggressive phenotype
    OC13.4
    Oral Communcations 13: Anteria and posteria pituitary
    Pharmacokinetics of somapacitan in individuals with hepatic impairment: an open-label, parallel group, phase 1 study
    OC13.5
    Oral Communcations 13: Anteria and posteria pituitary
    Pan-genomic classification of Pituitary Adenomas
    11:30 - 12:30 
    Oral Communications 14: Sex Hormones
    Salon Prestige Gratte-Ciel
    Chairs: Ilpo Huhtaniemi (Finland) & Michel Pugeat (France)
    OC14.1
    Oral Communications 14: Sex Hormones
    Testosterone replacement therapy is able to reduce prostate inflammation in men with BPH, metabolic syndrome and hypogonadism: preliminary results from a randomized placebo-controlled clinical trial
    OC14.2
    Oral Communications 14: Sex Hormones
    The effect of testosterone therapy on serum oestradiol levels in transgender men
    OC14.3
    Oral Communications 14: Sex Hormones
    First identification of Bone Morphogenic Protein Receptor variants as a cause of Primary Ovarian Insufficiency
    OC14.4
    Oral Communications 14: Sex Hormones
    Thyroid diseases in Danish women with polycystic ovary syndrome.
    OC14.5
    Oral Communications 14: Sex Hormones
    The pattern of cancer occurrence in Turner syndrome
    12:30 - 14:30 
    Lunch & Poster viewing
    Exhibition area
    12:45 - 13:30 
    ESE Annual General Meeting
    13:00 - 13:45 
    EU research funding - overview of opportunities and insights towards a successful application
    ECE HUB - Exhibition area
    Chairs: Felix Beuschlein (Switzerland) & Valerie Handweiler (France)
    Hub 1.6
    13:30 - 14:15 
    New Scientific Approach 5
    Forum 1
    Chair: Cristina Olarescu (Norway)
    NSA5
    New Scientific Approach 5
    Genome-wide effects of vitamin D on chromatin
    13:30 - 14:15 
    New Scientific Approach 6
    Forum 2
    Chair: Patrice Mollard (France)
    NSA6
    New Scientific Approach 6
    Brain imaging in conscious mice
    14:30 - 15:30 
    Debate 5: Should we treat young osteoporotic patients
    L'Amphithéâtre
    Chairs: Gesthimani Mintziori (Greece) & Carola Zillikens (The Netherlands)
    Calcium and Bone
    D5.2
    Debate 5: Should we treat young osteoporotic patients
    AGAINST: No, we shouldn't treat young osteoporotic patients
    D5.1
    Debate 5: Should we treat young osteoporotic patients
    FOR: Yes, we should treat young osteoporotic patients
    14:30 - 16:00 
    Symposium 26: Impact of thyroid disease on...
    Auditorium Lumière
    Chairs: Marek Ruchala (Poland) & Leonidas Duntas (Greece)
    Thyroid
    S26.1
    Symposium 26: Impact of thyroid disease on...
    Role of thyroid hormones in the pathogenesis and treatment of psychiatric disorders
    S26.2
    Symposium 26: Impact of thyroid disease on...
    Bone
    S26.3
    Symposium 26: Impact of thyroid disease on...
    Cardiac hypertrophy
    14:30 - 16:00 
    Symposium 27: What's new in reproductive endocrinology?
    Forum 1
    Chairs: Jenny Visser (The Netherlands) & Sophie Christin-Maitre (France)
    Reproductive Endocrinology
    S27.1
    Symposium 27: What's new in reproductive endocrinology?
    Dissecting Androgens in PCOS
    S27.2
    Symposium 27: What's new in reproductive endocrinology?
    Large scale genetic studies in male infertility
    S27.3
    Symposium 27: What's new in reproductive endocrinology?
    Menopause and cardiovascular risk
    14:30 - 16:00 
    Symposium 28: Vitamin D - non-skeletal effects in RCTs
    Salle Gratte-Ciel 1+2+3
    Chairs: Bruno Lapauw (Belgium) & Nuria Guanabens (Spain)
    Calcium and Bone
    S28.1
    Symposium 28: Vitamin D - non-skeletal effects in RCTs
    Vitamin D and its metabolites
    S28.2
    Symposium 28: Vitamin D - non-skeletal effects in RCTs
    Vitamin D and Type 1 Diabetes
    S28.3
    Symposium 28: Vitamin D - non-skeletal effects in RCTs
    How and when to measure Vitamin D
    14:30 - 16:00 
    Symposium 29: Endocrine controversies in sport
    Forum 2
    Chairs: Margaret Boguszewski (Brazil) & Martin Bidlingmaier (Germany)
    Environmental, Society and Governance
    S29.1
    Symposium 29: Endocrine controversies in sport
    Female hyperandrogenism and elite sport
    Stockholm, Sweden
    S29.2
    Symposium 29: Endocrine controversies in sport
    Performance enhancing drugs in young males
    S29.3
    Symposium 29: Endocrine controversies in sport
    Omics to fight doping
    14:30 - 16:00 
    Symposium 30: Personalised medicine in diabetes and obesity
    ENDORSED BY: EJE (European Journal of Endocrinology)
    Forum 3
    Chairs: Philippe Moulin (France) & Anneke van den Beukel (The Netherlands)
    Diabetes, Obesity and Metabolism
    S30.1
    Symposium 30: Personalised medicine in diabetes and obesity
    Mechanisms for Cardiovascular Complications of Diabetes – Implications for Personalized Therapy
    S30.2
    Symposium 30: Personalised medicine in diabetes and obesity
    New avenues for novel drugs to treat obesity
    Liverpool, United Kingdom
    S30.3
    Symposium 30: Personalised medicine in diabetes and obesity
    Curing diabetes with alternatives: bariatric surgery
    16:00 - 16:30 
    Tea & Coffee
    Exhibition area
    16:30 - 17:00 
    ESE Young Investigator Awards and Jens Sandahl Christansen Awards Ceremony
    L'Amphithéâtre
    Chairs: Manuel Tena-Sempere (Spain) & Sebastian Neggers (The Netherlands) & Françoise Borson-Chazot (France)
    EYIJC1
    ESE Young Investigator Awards and Jens Sandahl Christansen Awards Ceremony
    The metabolic effects of SGLT2 inhibitors – Does the increase in ketone bodies protect the heart?
    EYIJC2
    ESE Young Investigator Awards and Jens Sandahl Christansen Awards Ceremony
    Role of hypothalamic AMP-activated protein kinase (AMPK) in the central regulation of energy balance
    17:00 - 17:30 
    Plenary 7
    L'Amphithéâtre
    Chairs: Riccarda Granata (Italy) & Daniela Cota (France)
    PL7
    Plenary 7
    Diving into the brain basis of obesity/brain/periphery cross-talk in the regulation of peripheral metabolism
    17:30 - 17:45 
    Closing Ceremony
    L'Amphithéâtre
Dale Abel
Tue 21 14:30
S30.1
Symposium 30: Personalised medicine in diabetes and obesity
Mechanisms for Cardiovascular Complications of Diabetes – Implications for Personalized Therapy
Julio Abucham
Tue 21 08:00
MTE16.1
Meet The Expert 16: Interdisciplinary Endocrinology
Is it all in your head or just in the lab?
Peter Aldiss
Mon 20 10:20
S15.1
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Welcome and Introduction to EYES
Dr Cynthia Andoniadou
London, UK
Mon 20 15:30
S17.2
Symposium 17: Where Do Pituitary Tumours Come From
Pertubations in novel signalling pathways
London, UK
Carmen Aresta
Mon 20 12:00
OC7.1
Oral Communications 7: Endocrine Connections
Cortisol suppression or peripheral sensitivity and activation are associated with diabetes, hypertension and fragility fractures in postmenopausal eucortisolemic women
Alberto Arias
Mon 20 13:00
ERN1.1
Endo-ERN Session - Lunch Hub
Introduction and update on Endo-ERN
Mai Arlien-Søborg
Sun 19 12:36
OC3.4
Oral Communications 3: Cushing's and acromegaly
Restoration of basal glucose turnover after disease control in acromegaly depends on treatment modality: a prospective, investigator-initiated trial
Guillaume Assie
Tue 21 09:50
S24.1
Symposium 24: What's new in the Adrenal Cortex?
New genes, new understanding, new therapy
Marta Astigarraga
Sun 19 12:00
OC4.1
Oral Communications 4: Thyroid 2
Subclinical hypothyroidism throughout pregnancy in TPOAb positive pregnant women
Fereidoun Azizi
Mon 20 15:30
S16.2
Symposium 16: Thyroid in pregnancy
Thyroid disease and pregnancy outcomes
Elizabeth Baranowski
Tue 21 11:30
OC10.1
Oral Communications 10: Adrenal 1
Steroid Metabolomics: A Rapid Computational Approach for Accurate Differentiation of Inborn Disorders of Steroidogenesis.
Anne Barlier
Mon 20 12:36
OC7.4
Oral Communications 7: Endocrine Connections
Non-invasive detection of GNAS mutations causing McCune-Albright Syndrome with ddPCR on whole blood or circulating DNA.
Maria Barreto-Chaves
Tue 21 15:30
S26.3
Symposium 26: Impact of thyroid disease on...
Cardiac hypertrophy
Isabelle Beau
Tue 21 11:54
OC14.3
Oral Communications 14: Sex Hormones
First identification of Bone Morphogenic Protein Receptor variants as a cause of Primary Ovarian Insufficiency
Moncef Benkhalifa
Mon 20 10:20
S11.1
Symposium 11: EDCs and reproduction
Oocytes, Pesticides and IVF
Jerome Bertherat
France
Sun 19 08:05
PEM1.2
Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
The clinical view of Endocrinology in Europe
France
Laura Bessiène
Mon 20 12:12
OC7.2
Oral Communications 7: Endocrine Connections
Thyroid hormones are new key regulators of glucocorticoid metabolism
J. Betley
Mon 20 10:20
S13.1
Symposium 13: Central Control of Metabolism: Brain rules all
All optics in the metabolic brain
Anneke Beukel
Sun 19 08:25
PEM1.4
Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
The early-career perspective
Felix Beuschlein
Zürich, Switzerland
Sun 19 08:15
PEM1.3
Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
The research view of Endocrinology in Europe
Zürich, Switzerland
Martin Bidlingmaier
Tue 21 08:00
MTE16.2
Meet The Expert 16: Interdisciplinary Endocrinology
Is it all in your head or just in the lab?
Christophe Block
Sun 19 08:00
MTE1
Meet The Expert 1: Diabetes, Obesity and Metabolism
The road from flash and continuous glucose monitoring towards closed loop systems in diabetes
Bruce Blumberg
Sun 19 16:00
S7.3
Symposium 7: Endocrine Disrupting Chemicals
Endocrine Disrupting Chemicals and Obesity
Jens Bollerslev
Mon 20 09:20
EHM1
Plenary: European Hormone Medal Lecture
Monogenic Bone Disorders as a Model for Novel Treatment of Osteoporosis
Susan Bonner-Weir
Sun 19 17:00
PL3
Plenary 3
Pancreatic beta-cell ageing: Novel mechanisms and consequences in the management of diabetes
Benjamin Bouillet
Mon 20 11:05
S15.4
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
The role and cross-talk between incretin hormones and occurrence of Nonalcoholic steatohepatitis
Pierre Bouloux
Tue 21 08:00
MTE13
Meet The Expert 13: Interdisciplinary Endocrinology
Flushing, blushing and sweating
Nadia Bouzehouane
Sun 19 12:24
OC4.3
Oral Communications 4: Thyroid 2
PROGNOSTIC IMPACT OF MICROSCOPIC EXTRATHYROIDAL EXTENSION (mETE) ON RECURRENCE-FREE SURVIVAL IN PATIENTS WITH PAPILLARY THYROID CARCINOMA (PTC)
Jens Brüning
Tue 21 17:00
PL7
Plenary 7
Diving into the brain basis of obesity/brain/periphery cross-talk in the regulation of peripheral metabolism
Anca Bucur
Mon 20 14:00
NSA4
New Scientific Approach 4
When will AI take over from the endocrinologist?
Alexandre Buffet
Mon 20 12:00
OC5.1
Oral Communications 5: Adrenal 2
Positive impact of genetic test on the management and outcome of patients with paraganglioma and/or pheochromocytoma
Edit Buzás
Tue 21 09:50
D4.1
Debate 4: MicroRNAs as hormones?
FOR: MicroRNAs and extracellular vesicles as hormones?
Pauline Campos
Tue 21 13:30
NSA6
New Scientific Approach 6
Brain imaging in conscious mice
Carsten Carlberg
Tue 21 13:30
NSA5
New Scientific Approach 5
Genome-wide effects of vitamin D on chromatin
Davide Carvalho
Mon 20 08:00
MTE7
Meet The Expert 7: Pituitary and Neuroendocrinology
Non functional Pituitary Tumours - not always easy
Felipe Casanueva
Sun 19 11:20
SS1.3
Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - OK, so that’s why; more insight into the ins and outs of obesity - 4th Joint Global Symposium on Obesity
Social economic impact of the globesity pandemic
Olivera Casar-Borota
Mon 20 12:00
D3.1
Debate 3: Pituitary Pathology: Do we care?
FOR: Yes, we care about pituitary pathology
Ruth Casey
Cambridge, United Kingdom
Sun 19 12:00
OC1.1
Oral Communications 1: Calcium and Bone
Genetic testing for hereditary hyperparathyroidism in a large UK cohort
Cambridge, United Kingdom
Ashley Castellanos
Mon 20 10:45
S15.3
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Role of hypothalamic bile acid-TGR5 signaling in the regulation of energy balance
Mon 20 12:24
OC6.3
Oral Communications 6: Obesity 1
Role of hypothalamic bile acid-TGR5 signaling in the regulation of energy balance
Patrizio Caturegli
Sun 19 11:20
S4.1
Symposium 4: Immunology and endocrinology
Basic: Immunotherapy and endocrine disease
Isadora Cavalcante
Tue 21 12:06
OC10.4
Oral Communications 10: Adrenal 1
Cullin 3 is a partner of Armadillo Repeat Containing 5 (ARMC5), the product of the gene responsible for Primary Bilateral Macronodular Adrenal Hyperplasia
Carlos Celis-Morales
Mon 20 15:00
S20.1
Symposium 20: News on Nutrition: When to eat what
Precision Nutrition for managing obesity – Does it work?
Houaria Chanson
Sun 19 15:45
NDP1.4
Nurses Session 3: Professional Development
Parallel Workshops - MY DIABBY – Improving skills and competence in diabetes education
Kristina Chen
Sun 19 12:36
OC1.4
Oral Communications 1: Calcium and Bone
Risk of Sepsis, Respiratory Infections, and Kidney or Other Genitourinary (GU) Infections in Patients with Chronic Hypoparathyroidism (HypoPT): A Retrospective Cohort Study
Iacopo Chiodini
Tue 21 10:50
S24.3
Symposium 24: What's new in the Adrenal Cortex?
Autonomous cortisol secretion has cardiovascular consequences
Emanuel Christ
Mon 20 10:20
S14.1
Symposium 14: Innovations in NETs
Innovative imaging of insulinoma: The end of sampling…
Professor Mirjam Christ-Crain
Basel, Switzerland
Sat 18 18:20
EJE1
Plenary: European Journal of Endocrinology Award Lecture
New approaches in the differential diagnosis of Diabetes insipidus
Basel, Switzerland
Hye Chung
Tue 21 11:54
OC11.3
Oral Communications 11: Diabetes 2
Implications of circulating Meteorin-like (Metrnl) level in human subjects with type 2 diabetes
Marc Claret
Mon 20 10:50
S13.2
Symposium 13: Central Control of Metabolism: Brain rules all
Role of mitochondria/cell bioenergetics in CNS regulation of energy balance
Cyrille Confavreux
Tue 21 08:00
MTE12
Meet The Expert 12: Calcium and Bone
Fracture risk prediction in benign and tumoral bone: new insights
Martine Cools
Ghent, Belgium
Sun 19 15:30
S8.2
Symposium 8: Gender dysphoria
Gender Dysphoria –management of puberty
Ghent, Belgium
Eva Coopmans
Sun 19 12:48
OC3.5
Oral Communications 3: Cushing's and acromegaly
T2-signal intensity, SST receptor expression and first-generation somatostatin analogues efficacy predict hormone and tumor responses to pasireotide in acromegaly
Sabrina Corbetta
Sun 19 12:24
OC1.3
Oral Communications 1: Calcium and Bone
MENIN AND EZH2 ACTIVITIES MODULATE THE EXPRESSION OF THE LONG NON-CODING RNA HAR1B IN PARATHYROID TUMORS
Valérie Cormier-Daire
Paris, France
Tue 21 10:20
S21.2
Symposium 21: Rare Bone Disorders
New perspectives on the treatment of skeletal dysplasia
Paris, France
Mr Sherwin Criseno
Birmingham, UK
Sun 19 11:30
NS1.3
Nurses Session 1: Immuno-oncology (IO) meets Endocrinology
The Role of the Endocrine Nurse in Managing Patients with Immunotherapy-induced Endocrinopathies
Birmingham, UK
Daisy Crispim
Tue 21 12:06
OC11.4
Oral Communications 11: Diabetes 2
MiR-30e-5p expression is downregulated in plasma and urine of type 1 diabetic patients with diabetic kidney disease
Dr Rachel Crowley
Dublin, Ireland
Mon 20 10:55
NPD2.2
Nurses Session 4: Parathyroid Disorders
Hyperparathyroidism: Evidence-based screening and management
Dublin, Ireland
Michael Culler
Mon 20 12:00
OC6.1
Oral Communications 6: Obesity 1
Impaired Glucose Homeostasis in Leptin-Deficient ob/ob Mice is Corrected by AZP-3404, a 9-Amino Acid Peptide Analog Derived from Insulin-Like Growth Factor-Binding Protein 2, a Key Mediator of Leptin Action
Thomas Cuny
Mon 20 11:45
S15.6
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Closing remarks
Birgitte Damholt
Tue 21 12:06
OC13.4
Oral Communcations 13: Anteria and posteria pituitary
Pharmacokinetics of somapacitan in individuals with hepatic impairment: an open-label, parallel group, phase 1 study
Alberto Davalos
Tue 21 09:50
D4.2
Debate 4: MicroRNAs as hormones?
AGAINST: MicroRNAs as hormones?
Justine Defreyne
Tue 21 12:18
OC12.5
Oral Communications 12: Endocrine Connections 2
Sexual desire in transgender persons in relation with gender affirming hormone treatment. Results from ENIGI, a large multicenter prospective cohort study in transgender people
Tue 21 11:42
OC14.2
Oral Communications 14: Sex Hormones
The effect of testosterone therapy on serum oestradiol levels in transgender men
Olaf Dekkers
Tue 21 10:50
PS1.3
Publishing Session
European Journal of Endocrinology - ‘Common methodological flaws and how to avoid them’
Jacques Drouin
Montreal, Canada
Mon 20 15:00
S17.1
Symposium 17: Where Do Pituitary Tumours Come From
Specification of cell fate
Montreal, Canada
Laurence Dumeige
Tue 21 11:42
OC12.2
Oral Communications 12: Endocrine Connections 2
Epigenetic Programming of Transgenerational Hypertension in Preterm Birth Mice
Maeve Durkan
Tue 21 11:45
UEMS1.1
UEMS Session
The role of UEMS in Europe and the distinct and independent but allied pathway with ESE
Graeme Eisenhofer
Dresden , Germany
Sun 19 15:30
S9.1
Symposium 9: Controversies in adrenal disease
Metanephrines - plasma or urine?
Dresden , Germany
Eva- Erfurth
Mon 20 11:20
S12.3
Symposium 12: Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
How to manage the long-term consequences of hypothalamic damages
Eda Ertorer
Mon 20 08:00
MTE10
Meet The Expert 10: Reproductive Endocrinology
NCAH and Female reproduction
Patrick Fénichel
Mon 20 10:50
S11.2
Symposium 11: EDCs and reproduction
Testicular germ cell cancer: role of fœtal exposure to endocrine disruptors
Fernando Fernandez-Aranda
Sun 19 12:00
C1.1
Controversies Session: Food addiction in humans: to be or not to be?
Food addiction in humans: to be or not to be?
Serge Ferrari
Tue 21 14:30
D5.1
Debate 5: Should we treat young osteoporotic patients
FOR: Yes, we should treat young osteoporotic patients
Anna Ferrulli
Mon 20 12:12
OC6.2
Oral Communications 6: Obesity 1
Deep Transcranial Magnetic Stimulation modulates body temperature in obesity
Panagiotis Filis
Tue 21 10:50
S25.3
Symposium 25: Late breaking
Maternal smoking and high BMI disrupt thyroid gland development
Jean Fini
Sun 19 15:00
S7.1
Symposium 7: Endocrine Disrupting Chemicals
Endocrine Disrupting Chemicals and Thyroid
Antonella Forlino
Pavia, Italy
Tue 21 09:50
S21.1
Symposium 21: Rare Bone Disorders
Animal model of bone fragility
Pavia, Italy
Paolo Forni
Mon 20 15:00
S18.1
Symposium 18: Congenital Hypogonadotropic Hypogonadism: New insights into GnRH Regulation
GnRH migration and vomeronasal neurons
Christelle Fouchardiere
Sun 19 10:20
NS1.1
Nurses Session 1: Immuno-oncology (IO) meets Endocrinology
Overview of Immunotherapy: Indications and adverse effects
Athanasios Fountas
Birmingham, UK
Sun 19 12:12
OC3.2
Oral Communications 3: Cushing's and acromegaly
Outcomes after primary treatment for Nelson’s syndrome: a study from 13 UK centres
Birmingham, UK
Meir Frankel
Sun 19 12:12
OC4.2
Oral Communications 4: Thyroid 2
Thyroid Dysfunction And Mortality In Cardiovascular Hospitalized Patients – A 12 year Follow-up Observational Study
Delphine Franssen
Mon 20 12:00
OC8.1
Oral Communications 8: Reproduction 1
Dissecting the roles of KNDy-derived kisspeptins in the control of reproduction: Generation and characterization of the Tac2-specific Kiss1 KO (TaK-KO) mouse
Graeme Fraser
Mon 20 12:48
OC8.5
Oral Communications 8: Reproduction 1
The Neurokinin 3 Receptor Antagonist, Fezolinetant, Is Effective in Treatment of Menopausal Vasomotor Symptoms: Responder Analysis Results From a Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Study
Avi Friedman
Sat 18 19:00
PL1
Plenary 1
Designing Cities and Homes as Exercise Machines: Helping endocrinologists to fight metabolic disease
Laura Fugazzola
Sun 19 10:20
S1.1
Symposium 1: Thyroid in cancer
What is the value of molecular markers in nodules
Jorge García-Giménez
Mon 20 12:00
OC9.1
Oral Communications 9: Thyroid 1
3D mapping and in silico predictions of the DEHAL1 enzyme as a tool to discriminate pathogenic mutations from non-functional variants in hypothyroidism
Chiranjit Ghosh
Sun 19 12:24
OC2.3
Oral Communications 2: Diabetes 1
Identification of oxygen-18 isotope of breath carbon dioxide as a non-invasive marker to distinguish type 1 and type 2 diabetes
Andrea Giustina
Sun 19 08:00
PEM1.1
Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
Introduction: Why Policy and Advocacy matters, also to endocrinology - Includes methodology, response, demographics
Sun 19 08:35
PEM1.5
Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
Closing remarks and discussion
Dorte Glintborg
Tue 21 12:06
OC14.4
Oral Communications 14: Sex Hormones
Thyroid diseases in Danish women with polycystic ovary syndrome.
Lars Gormsen
Sun 19 08:00
MTBS1
Meet The Basic Scientist 1: Interdisciplinary Endocrinology
New tracers for PET in humans and rodents: Hopes, aims and current evidence
Laura Graaff
Tue 21 08:00
MTE14
Meet The Expert 14: Interdisciplinary Endocrinology
How multidisciplinary care and tailor-made transition save lives of young adults with Prader-Willi syndrome
Claus Gravholt
Mon 20 08:00
MTE8
Meet The Expert 8: Reproductive Endocrinology
Co-morbidities in Turner syndrome
Claus Gravholt
Tue 21 12:18
OC14.5
Oral Communications 14: Sex Hormones
The pattern of cancer occurrence in Turner syndrome
Nuria Guanabens
Tue 21 08:00
MTE11
Meet The Expert 11: Calcium and Bone
Shifting treatment paradigms in osteoporosis
Keren Halpern
Sun 19 14:00
NSA2
New Scientific Approach 2
Single cell spatial reconstruction of endocrine organs
Erin Hanlon
Sun 19 10:50
SS1.2
Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - OK, so that’s why; more insight into the ins and outs of obesity - 4th Joint Global Symposium on Obesity
Sleep Deficiency: A Pathway to Obesity
Shelley Harris
Sun 19 12:48
OC2.5
Oral Communications 2: Diabetes 1
5β-reductase (AKR1D1) deletion drives hepatic inflammation, fibrosis and tumour development in vitro and in vivo
Anna Hawkins
London, UK
Sun 19 15:30
NPD1.2
Nurses Session 3: Professional Development
2018 Poster Award Presentation: Testosterone replacement: 'The best practice' and the role of the Endocrine Nurse
London, UK
Ansgar Heck
Mon 20 10:20
NPD2.1
Nurses Session 4: Parathyroid Disorders
Hypoparathyroidism: Aetiology, diagnosis and challenges in management
James Hennessey
Mon 20 10:20
D2.2
Debate 2: T4 is not enough
AGAINST: No, T4 is enough
Angelica Hirschberg
Stockholm, Sweden
Tue 21 14:30
S29.1
Symposium 29: Endocrine controversies in sport
Female hyperandrogenism and elite sport
Stockholm, Sweden
Jeff Holly
Sun 19 10:20
SS1.1
Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - OK, so that’s why; more insight into the ins and outs of obesity - 4th Joint Global Symposium on Obesity
Obesity gives you cancer: the bigger picture!
Dr Sasha Howard
London, UK
Sun 19 11:20
S2.3
Symposium 2: Trends in Puberty
Genetic basis in puberty
London, UK
Linda Humbert
Mon 20 12:48
OC7.5
Oral Communications 7: Endocrine Connections
Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) syndrome : French prospective study in a cohort of 25 patients
Professor  Eystein Husebye
Bergen, Norway
Mon 20 15:00
S19.1
Symposium 19: Adrenal Insufficiency
New insights into autoimmune adrenal insufficiency

Unknown speaker

Bergen, Norway
Mirela Ilie
Tue 21 12:00
UEMS1.3
UEMS Session
The microenvironment of pituitary neuroendocrine tumors: focus on folliculostellate cells
María Insenser
Tue 21 09:50
S23.1
Symposium 23: PCOS: Can we personalise treatment?
Gut brain axis
Andrea Isidori
Sapienza University of Rome, Italy
Sun 19 10:50
S3.2
Symposium 3: Circadian clocks: from pathophysiology to chronomedicine
Fixing the Broken Clock in Adrenal Disorders
Sapienza University of Rome, Italy
Arnaud Jannin
Mon 20 12:36
OC6.4
Oral Communications 6: Obesity 1
Fat mass impact of Sirolimus after clinical islet transplantation, a case control study
Emmanuele Jannini
Sun 19 15:00
S8.1
Symposium 8: Gender dysphoria
Psychoendocrinology Of Gender Dysphoria
John-Olov Jansson
Tue 21 08:00
MTBS3
Meet The Basic Scientist 3
The “Gravitostat” – How does it relate to hormones?
Andrzej Januszewicz
Sun 19 08:00
MTE3
Meet The Expert 3: Adrenal and Neuroendocrine Tumours
The management of primary aldosteronism
Professsor  Kassim	 Javaid
Oxford, UK
Tue 21 10:50
S21.3
Symposium 21: Rare Bone Disorders
Osteogenesis imperfecta throughout life
Oxford, UK
Juan Jiménez-Vacas
Mon 20 12:24
OC5.3
Oral Communications 5: Adrenal 2
SF3B1 as novel target for the treatment of multiple endocrine-related cancers
Gudmundur Johannsson
Mon 20 15:30
S19.2
Symposium 19: Adrenal Insufficiency
Long-term results of slow acting glucocorticoids - are they really better?
Tareq Juratli
Mon 20 10:50
S12.2
Symposium 12: Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
New potential treatment alternatives in patients with papillary craniopharyngioma
Professor George Kahaly
Mianz, Germany
Tue 21 08:50
PL6
Plenary 6
Treatment strategies for Graves orbitopathy
Mianz, Germany
Peter Kamenicky
Paris, France
Mon 20 16:00
S17.3
Symposium 17: Where Do Pituitary Tumours Come From
From Lab to Clinic - Can we translate into effective therapeutics
Paris, France
Olle Kämpe
Stockholm, Sweden
Sun 19 11:00
S4.3
Symposium 4: Immunology and endocrinology
Transitional: The diagnostic value of autoimmune antibodies in endocrine disorders
Stockholm, Sweden
Yasmine Kemkem
Mon 20 12:48
OC9.5
Oral Communications 9: Thyroid 1
Deciphering the origin of the sexually dimorphic thyrotropin secretion in mouse models.
Marianne Klose
Tue 21 08:00
MTE15
Meet The Expert 15: Pituitary and Neuroendocrinology
To what degree does hypopituitarism exist after TBI?
Tomaz Kocjan
Mon 20 08:00
MTE6
Meet The Expert 6: Calcium and Bone
Primary Hyperparathyroidism: Surgical vs Medical Therapy
Josef Koehrle
Tue 21 09:50
PS1.1
Publishing Session
Endocrine Connections - ‘Increase the visibility of your research: open access and more’
Nils Krone
Sheffield, UK
Mon 20 16:00
S19.3
Symposium 19: Adrenal Insufficiency
Optimising care delivery in Congenital Adrenal Hyperplasia
Sheffield, UK
Irene Lambrinoudaki
Tue 21 15:30
S27.3
Symposium 27: What's new in reproductive endocrinology?
Menopause and cardiovascular risk
Matthias Laudes
Sun 19 11:20
S5.3
Symposium 5: Microbiota as new treatment for diabetes and metabolic disease
Targeted Microbiome Intervention for handling insulin resistance
Laurence Leenhardt
Sun 19 08:00
MTE5
Meet The Expert 5: Thyroid
Risk classification of thyroid nodules by ultrasound and indications for FNA
Hervé Lefebvre
Mon 20 17:20
PL5
Plenary 5
Paracrine regulation of the adrenal cortex
Bernard Lerer
Tue 21 14:30
S26.1
Symposium 26: Impact of thyroid disease on...
Role of thyroid hormones in the pathogenesis and treatment of psychiatric disorders
Deborah Levie
Mon 20 16:00
S16.3
Symposium 16: Thyroid in pregnancy
Thyroid disease and offspring development
Jean Lifante
Mon 20 11:30
NPD2.3
Nurses Session 4: Parathyroid Disorders
Parathyroid Surgery: Indications and Consequences
Qiaoran Liu
Sun 19 12:12
OC2.2
Oral Communications 2: Diabetes 1
Elevated glucose uptake in skeletal muscle with increased sarcolemma translocation of GLUT4 and glycogen synthesis contributes to bariatric surgery mediated diabetes remission
Dr Sofia Llahana
London, UK
Sun 19 15:00
NPD1.1
Nurses Session 3: Professional Development
Update from the ESE Nurses Working Group, future projects and presentation of Poster Awards
London, UK
Sun 19 15:45
NPD1.3
Nurses Session 3: Professional Development
Parallel Workshops - How to use the Textbook in Advanced Endocrine Nursing and Competency Framework to develop your clinical practice (Adrenal Insufficiency)
London, UK
Alejandro Lomniczi
Sun 19 10:20
S2.1
Symposium 2: Trends in Puberty
Exploring the Epigenetic Landscape of Puberty
Miguel López
Tue 21
EYIJC2
ESE Young Investigator Awards and Jens Sandahl Christansen Awards Ceremony
Role of hypothalamic AMP-activated protein kinase (AMPK) in the central regulation of energy balance
Andrea Lovdel
Mon 20 10:25
S15.2
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Investigating glucocorticoids as the mechanism behind bone marrow adiposity expansion during caloric restriction
Raul Luque
Tue 21 10:50
S22.3
Symposium 22: The Pituitary As Metabolic Sensor
Bidirectional interrelationship between growth hormone and metabolism
Djuro Macut
Sun 19 12:00
ECAS1.1
ESE Council of Affiliated Societies Session
Mapping Endocrinology in Europe - ECAS report
Katharina Main
Copenhagen, Denmark
Mon 20 11:20
S11.3
Symposium 11: EDCs and reproduction
Mitigating against endocrine disruption in pregnancy
Copenhagen, Denmark
Sari Mäkimattila
Sun 19 12:00
OC2.1
Oral Communications 2: Diabetes 1
EVERY FIFTH PATIENT WITH TYPE 1 DIABETES SUFFERS FROM AN ADDITIONAL ENDOCRINOLOGICAL AUTOIMMUNE DISEASE – A FINNISH NATIONWIDE STUDY
Beata Malachowska
Mon 20 11:25
S15.5
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Lysophosphatidic acid in pathogenesis of HNF1B-MODY syndrome
Claudio Marcocci
Sun 19 16:00
S10.3
Symposium 10: Cancer drug-induced osteoporosis
TSH-suppressive therapy and bone
Pedro Marques
Tue 21 11:54
OC13.3
Oral Communcations 13: Anteria and posteria pituitary
Pituitary tumour-derived chemokines modulate immune cell infiltrates in the tumour microenvironment leading to aggressive phenotype
George Mastorakos
Sun 19 12:20
ECAS1.2
ESE Council of Affiliated Societies Session
Centres of special interest - how could we move on?
Professor  Chris McCabe
Birmingham, UK
Sun 19 10:50
S1.2
Symposium 1: Thyroid in cancer
Iodine refractoriness in thyroid cells
Birmingham, UK
Marco Medici
Sun 19 15:00
S6.1
Symposium 6: A better life with thyroid hormone
Prediction of the thyroid axis set-point
Emilie Merlen
Tue 21 12:06
OC12.4
Oral Communications 12: Endocrine Connections 2
Long-term follow-up of antitumoral immunotherapy- induced hypophysitis in Lille hospital, France
Michal Meron
Mon 20 12:48
OC6.5
Oral Communications 6: Obesity 1
Lipolysis Defect in White Adipose Tissue and Rapid Weight Regaining
Andrea Messina
Mon 20 15:30
S18.2
Symposium 18: Congenital Hypogonadotropic Hypogonadism: New insights into GnRH Regulation
Flipping the GnRH switch with microRNAs
Radu Mihai
Sun 19 15:00
S9.3
Symposium 9: Controversies in adrenal disease
Is there a role for subtotal adrenalectomy
Gesthimani Mintziori
Tue 21 10:20
PS1.2
Publishing Session
EDM Case Reports - ‘Top tips for writing and submitting an article – an early career researcher’s perspective’
Nicolas Morel-Journel
Sun 19 16:00
S8.3
Symposium 8: Gender dysphoria
Gender reassignment surgery in dysphoria
Daniel Morganstein
London, UK
Sun 19 10:55
NS1.2
Nurses Session 1: Immuno-oncology (IO) meets Endocrinology
Immunotherapy-induced Endocrinopathies: Assessment, Management and Monitoring
London, UK
Angel Nadal
Sun 19 15:30
S7.2
Symposium 7: Endocrine Disrupting Chemicals
Endocrine Disrupting Chemicals and Diabetes Mellitus
Narjes Nasiri-Ansari
Sun 19 12:36
OC2.4
Oral Communications 2: Diabetes 1
Empagliflozin attenuates the progression of atherosclerosis in APO-E knockout mice
Victor Navarro
Tue 21 09:50
S22.1
Symposium 22: The Pituitary As Metabolic Sensor
Kiss1 as integrator of endocrine and metabolic function in the hypothalamic-pituitary axis
Mario Neou
Tue 21 12:18
OC13.5
Oral Communcations 13: Anteria and posteria pituitary
Pan-genomic classification of Pituitary Adenomas
Romana Netea-Maier
Sun 19 12:48
OC4.5
Oral Communications 4: Thyroid 2
A comprehensive assessment of the interplay between the thyroid function and the immune system: results from the Human Functional Genomics Project
Hannah Nieto
Birmingham, United Kingdom
Mon 20 12:24
OC9.3
Oral Communications 9: Thyroid 1
Novel driver mutations in thyroid cancer recurrence
Birmingham, United Kingdom
Max Nieuwdorp
Sun 19 10:50
S5.2
Symposium 5: Microbiota as new treatment for diabetes and metabolic disease
Fecal transplantation: Myth or reality
Ruth Northway
Sun 19 12:00
MTNE1
Nurses Session 2: Meet the Nurse Expert
Nursing Approach To The Holistic Care of Patients with Intellectual Disability
Birte Nygaard
Mon 20 10:20
D2.1
Debate 2: T4 is not enough
FOR: Yes, T4 is not enough
Barbara Obermayer-Pietsch
Tue 21 14:30
D5.2
Debate 5: Should we treat young osteoporotic patients
AGAINST: No, we shouldn't treat young osteoporotic patients
Ken Ong
Cambridge, United Kingdom
Sun 19 09:20
PL2
Plenary 2
Genetic epidemiology of puberty timing and reproductive lifespan
Cambridge, United Kingdom
Professor Anne-Simone Parent
Liège, Belgium
Sun 19 10:50
S2.2
Symposium 2: Trends in Puberty
Endocrine disruptors in puberty
Liège, Belgium
Valentina Pautasso
Mon 20 12:36
OC9.4
Oral Communications 9: Thyroid 1
Resistance to thyroid hormone alpha associated with early-onset severe NASH
Simon Pearce
Newcastle, UK
Sun 19 16:00
S6.3
Symposium 6: A better life with thyroid hormone
Subclinical hypothyroidism in the elderly
Newcastle, UK
Sergio Pedraza-Arévalo
Mon 20 12:36
OC5.4
Oral Communications 5: Adrenal 2
The splicing factor NOVA1 is overexpressed in pancreatic neuroendocrine tumors and related to increased aggressiveness and malignancy
Mariasara Persano
Tue 21 12:18
OC11.5
Oral Communications 11: Diabetes 2
Bone metabolism and circulating myeloid calcifying cells in diabetic post menopausal women: a case-control study
Rosario Pivonello
Sun 19 12:00
OC3.1
Oral Communications 3: Cushing's and acromegaly
Osilodrostat provides clinical benefit over 48 weeks in patients with Cushing disease: Results from the LINC 3 study
Stephanie Puget
Mon 20 10:20
S12.1
Symposium 12: Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
The view of the surgeon: When, how much and when to refrain from surgery?
Elena Rapizzi
Mon 20 12:12
OC5.2
Oral Communications 5: Adrenal 2
Pheochromocytoma aggressiveness induced by tumor microenvironment depends on the SDH subunit involved
Giulia Rastrelli
Tue 21 11:30
OC14.1
Oral Communications 14: Sex Hormones
Testosterone replacement therapy is able to reduce prostate inflammation in men with BPH, metabolic syndrome and hypogonadism: preliminary results from a randomized placebo-controlled clinical trial
Professor Martina Rauner
Dresden, Germany
Sun 19 15:00
S10.1
Symposium 10: Cancer drug-induced osteoporosis
Mechanisms of skeletal metastasis (could be induced by breast cancer or prostate cancer or both)
Dresden, Germany
Dr David Ray
Manchester, UK
Sun 19 10:20
S3.1
Symposium 3: Circadian clocks: from pathophysiology to chronomedicine
Circadian control of glucocorticoid function
Manchester, UK
Julie Refardt
Tue 21 11:42
OC13.2
Oral Communcations 13: Anteria and posteria pituitary
Empagliflozin increases sodium-levels in patients with the syndrome of inappropriate antidiuretic hormone secretion – a randomized, double-blind, placebo-controlled trial
Professor Nicole Reisch
Munich, Germany
Sun 19 08:00
MTE4
Meet The Expert 4: Adrenal and Neuroendocrine Tumours
Management of a life-long disease in CAH
Munich, Germany
Lars Rejnmark
Mon 20 13:01
ERN1.2
Endo-ERN Session - Lunch Hub
Core activities of Endo-ERN in close collaboration with ESE and ESPE: the multi-disciplinary approach
Lucie Renault
Mon 20 12:12
OC8.2
Oral Communications 8: Reproduction 1
AMH is a predictive factor for successful sperm retrieval in non-mosaic Klinefelter syndrome patients
Juan Rivas
Mon 20 12:36
OC8.4
Oral Communications 8: Reproduction 1
Conditional ablation of AMP-Activated Protein Kinase (AMPK) in GnRH Neurons Reveals Specific Roles in Reproductive and Metabolic Homeostasis
Graham Roberts
Waterford, Ireland
Tue 21 11:30
UEMS1.2
UEMS Session
Update on European Exam in Endocrinology
Waterford, Ireland
Denise Robertson
Mon 20 15:30
S20.2
Symposium 20: News on Nutrition: When to eat what
Is limiting the timing of food intake a viable nutritional approach?
Mercedes Robledo
Sun 19 16:00
S9.2
Symposium 9: Controversies in adrenal disease
The do's and don'ts of genetic testing in phaeochromocytoma
David Rodriguez
Mon 20 12:24
OC8.3
Oral Communications 8: Reproduction 1
Endocrine Disruptors transgenerationally alters pubertal timing through epigenetic reprogramming of the hypothalamus.
Cristina Ronchi
Birmingham, United Kingdom
Tue 21 12:18
OC10.5
Oral Communications 10: Adrenal 1
Cyclin Dependent Kinase 4 as promising drug target in adrenocortical carcinoma
Birmingham, United Kingdom
Pim Ronde
Tue 21 15:00
S29.2
Symposium 29: Endocrine controversies in sport
Performance enhancing drugs in young males
Emilio Ros
Mon 20 16:00
S20.3
Symposium 20: News on Nutrition: When to eat what
PREDIMED Plus trial - energy-restricted Mediterranean diet plus exercise and metabolic health
Guadalupe Sabio
Tue 21 09:50
S25.1
Symposium 25: Late breaking
Liver Stress kinases – crossroad between obesity and liver cancer (Source paper: Nature 2019)
Prudencio Sáez-Martínez
Tue 21 11:54
OC12.3
Oral Communications 12: Endocrine Connections 2
Neuronostatin and GPR107 system: a novel therapeutic circuit in Prostate Cancer.
Maria Salerno
Sun 19 15:30
S6.2
Symposium 6: A better life with thyroid hormone
Subclinical hypothyroidism in children
Renato Santini
Mon 20 15:00
GS1
Guidelines Session: ESE Clinical Practice Guidelines on the Endocrine Work-up in Obesity
Topics: 'Hormonal alterations in obesity', 'Thyroid dysfunction', 'Hypercortisolism', 'Gonadal dysfunction' & 'cther hormones'
Federica Saponaro
Sun 19 12:12
OC1.2
Oral Communications 1: Calcium and Bone
Urinary magnesium as predictor of nephrolithiasis in patients with asymptomatic primary hyperparathyroidism
Sven Schlaffer
Mon 20 12:00
D3.2
Debate 3: Pituitary Pathology: Do we care?
AGAINST: No, we don't care about pituitary pathology
Martin Schlumberger
Sun 19 11:20
S1.3
Symposium 1: Thyroid in cancer
New paradigms in the treatment of low risk thyroid cancer
Ulrich Schweizer
Mon 20 12:12
OC9.2
Oral Communications 9: Thyroid 1
Direct evidence for disulfides in the mechanism of deiodinase 1
David Selva
Tue 21 11:42
OC11.2
Oral Communications 11: Diabetes 2
Molecular Mechanisms Regulating Hepatic Sex Hormone-Binding Globulin Production. Clinical Implications in Human Diseases.
Jochen Seufert
Tue 21 15:30
S30.3
Symposium 30: Personalised medicine in diabetes and obesity
Curing diabetes with alternatives: bariatric surgery
Mojca Sever
Tue 21 10:50
S23.3
Symposium 23: PCOS: Can we personalise treatment?
Treatment options in cardiometabolic PCOS phenotype
Paul Sibilia
Sun 19 12:36
OC4.4
Oral Communications 4: Thyroid 2
Cardiac and vascular characteristics of thyroid hormone resistance syndrome in France
Heide Siggelkow
Sun 19 12:48
OC1.5
Oral Communications 1: Calcium and Bone
Renal Function in 711 patients with Hypoparathyroidism during more than 4 years of therapy
Anne Skakkebæk
Mon 20 08:00
MTE9
Meet The Expert 9: Reproductive Endocrinology
Co-morbidities in Klinefelter syndrome
Rima Smith
Tue 21 10:20
S25.2
Symposium 25: Late breaking
LT4 treatment and pregnancy outcomes in TPOab positive women: results of the TABLET Trial
Esben Søndergaard
Tue 21
EYIJC1
ESE Young Investigator Awards and Jens Sandahl Christansen Awards Ceremony
The metabolic effects of SGLT2 inhibitors – Does the increase in ketone bodies protect the heart?
Halfdan Sorbye
Mon 20 10:50
S14.2
Symposium 14: Innovations in NETs
A role for radionuclide therapy for high-grade NETs
Jean Souberbielle
Tue 21 15:30
S28.3
Symposium 28: Vitamin D - non-skeletal effects in RCTs
How and when to measure Vitamin D
Günter Stalla
Sat 18 17:45
GH1
Plenary: Geoffrey Harris Award Lecture
Translational research in pituitary disease
Danielle Steenvoorden
Mon 20 13:02
ERN1.3
Endo-ERN Session - Lunch Hub
Core activities of Endo-ERN in close collaboration with ESE and ESPE: the multi-disciplinary approach
Maria Stelmachowska-Banas
Sun 19 10:50
S4.2
Symposium 4: Immunology and endocrinology
Clinical: Immunotherapy and endocrine disease
Gabor Tamas
Mon 20 14:00
NSA3
New Scientific Approach 3
Intelligent image based in situ single cell isolation
Sopio Tatulashvili
Tue 21 11:30
OC11.1
Oral Communications 11: Diabetes 2
Hormonal factors and type 2 diabetes risk in women: a 22 year follow-up study on more than 83 000 women from the E3N cohort study
Dr Henri Timmers
Nijmegen, The Netherlands
Sun 19 15:15
D1.1
Debate 1: Surgical treatment of phaeochromocytoma - query pre-treatment?
FOR: Surgical treatment of phaeochromocytoma - query pre-treatment?
Nijmegen, The Netherlands
Giovanni Tulipano
Tue 21 10:20
S22.2
Symposium 22: The Pituitary As Metabolic Sensor
How treatments with endocrine & metabolic drugs influence pituitary cell function?
Frank Tuttelmann
Tue 21 15:00
S27.2
Symposium 27: What's new in reproductive endocrinology?
Large scale genetic studies in male infertility
David Unuane
Mon 20 15:00
S16.1
Symposium 16: Thyroid in pregnancy
Thyroid autoimmunity and fertility
Anna Vaczlavik
Tue 21 11:54
OC10.3
Oral Communications 10: Adrenal 1
Genetic predisposition to Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH): next generation sequencing ARMC5, NR3C1 (Glucocorticoid Receptor) and PDE11A4 (Phosphodiesterase 11) in 389 patients
Roberto Vettor
Sun 19 08:00
MTE2
Meet The Expert 2: Diabetes, Obesity and Metabolism
Long-term endocrine-metabolic effects of bariatric surgery: do the benefits really outweigh the risks?
Hubert Vidal
Sun 19 10:20
S5.1
Symposium 5: Microbiota as new treatment for diabetes and metabolic disease
Human gut microbiome: hopes, threats and promises
Suvi Virtanen
Tue 21 15:00
S28.2
Symposium 28: Vitamin D - non-skeletal effects in RCTs
Vitamin D and Type 1 Diabetes
Giovanni Vitale
Mon 20 11:20
S14.3
Symposium 14: Innovations in NETs
Fishing for NETs
Géraldine Vitellius
Tue 21 11:42
OC10.2
Oral Communications 10: Adrenal 1
Glucocorticoid resistance patients exhibit defective cortisol metabolism, responsible for functional hypermineralocorticism
Kirsty Walters
Tue 21 14:30
S27.1
Symposium 27: What's new in reproductive endocrinology?
Dissecting Androgens in PCOS
Professor Martin Walz
Essen, Germany
Sun 19 15:15
D1.2
Debate 1: Surgical treatment of phaeochromocytoma - query pre-treatment?
AGAINST: Surgical treatment of phaeochromocytoma - query pre-treatment?
Essen, Germany
Guan Wang
Tue 21 15:30
S29.3
Symposium 29: Endocrine controversies in sport
Omics to fight doping
Susan Webb
Barcelona, Spain
Mon 20 16:50
CET1
Plenary: Clinical Endocrinology Trust Lecture
How can patients perception of outcome be improved after controlling pituitary disease?
Barcelona, Spain
Andrea Widmer
Mon 20 12:48
OC5.5
Oral Communications 5: Adrenal 2
Impact of adrenal insufficiency on patient-centred health care outcomes in adult medical inpatients
John Wilding
Liverpool, United Kingdom
Tue 21 15:00
S30.2
Symposium 30: Personalised medicine in diabetes and obesity
New avenues for novel drugs to treat obesity
Liverpool, United Kingdom
Tracy Williams
Tue 21 10:20
S24.2
Symposium 24: What's new in the Adrenal Cortex?
Primary hyperaldosteronism: does our treatment work?
Graham Williams
Tue 21 15:00
S26.2
Symposium 26: Impact of thyroid disease on...
Bone
Elizabeth Winter
Tue 21 11:30
OC12.1
Oral Communications 12: Endocrine Connections 2
Weekly shifts in light-dark cycle disrupt circadian clock gene expression in bone and reduce bone turnover
Elisabeth Winter
Tue 21 14:30
S28.1
Symposium 28: Vitamin D - non-skeletal effects in RCTs
Vitamin D and its metabolites
Bettina Winzeler
Tue 21 11:30
OC13.1
Oral Communcations 13: Anteria and posteria pituitary
Arginine-stimulated Copeptin Measurements - A new Test for Diabetes Insipidus
Eckhard Wolf
Mon 20 08:00
MTBS2
Meet The Basic Scientist 2
Genetically tailored pig models in translational endocrine and metabolic research
Professor Stefan Wudy
Giessen, Germany
Sun 19 14:00
NSA1
New Scientific Approach 1
Steroidomics
Giessen, Germany
Chris Yedinak
USA), Lisa Shepherd
Sun 19 15:45
NPD1.5
Nurses Session 3: Professional Development
Parallel Workshops - How to use the Textbook in Advanced Endocrine Nursing and Competency Framework to develop your clinical practice (Acromegaly)
USA), Lisa Shepherd
Professor  Giles Yeo
Cambridge, UK
Mon 20 11:20
S13.3
Symposium 13: Central Control of Metabolism: Brain rules all
Genetics of appetite regulation
Cambridge, UK
Bulent Yildiz
Sun 19 12:40
ECAS1.3
ESE Council of Affiliated Societies Session
3rd Early Career Clinical Endocrinologist session at EndoBridge 2019 - referring of a patient from primary care to the endocrinology unit
Takashi Yoshimura
Sun 19 11:20
S3.3
Symposium 3: Circadian clocks: from pathophysiology to chronomedicine
Light Up Your Sex Life!
Jacques Young
Mon 20 16:00
S18.3
Symposium 18: Congenital Hypogonadotropic Hypogonadism: New insights into GnRH Regulation
Congenital Hypogonadotropic Hypogonadism: Clinical Perspectives
Jiang-Ning Zhou
Sun 19 12:24
OC3.3
Oral Communications 3: Cushing's and acromegaly
Monosynaptic inputs to corticotropin-releasing hormone neuron in hypothalamic paraventricular nucleus of mice at the whole brain scale
Volha Zhukouskaya
Mon 20 12:24
OC7.3
Oral Communications 7: Endocrine Connections
HIGHER DOSE OF BUROSUMAB IS NEEDED FOR TREATMENT OF CHILDREN WITH SEVER FORMS OF X-LINKED HYPOPHOSPHATEMIA
Juleen Zierath
Mon 20 08:50
PL4
Plenary 4
Exercise training in the management of T2D
Carola Zillikens
Sun 19 15:30
S10.2
Symposium 10: Cancer drug-induced osteoporosis
Aromatase inhibitors and bone
Workshop 1
Sat 18 09:00
Pre-congress Courses
Oral 4
Sun 19 12:00
Oral Communications 1: Calcium and Bone
Salle Gratte-Ciel 1+2+3
Chairs: Lars Rejnmark (Denmark) & Peter Kamenicky (France)
OC1
Sun 19 12:00
OC1.1
Oral Communications 1: Calcium and Bone
Genetic testing for hereditary hyperparathyroidism in a large UK cohort
Cambridge, United Kingdom
Sun 19 12:12
OC1.2
Oral Communications 1: Calcium and Bone
Urinary magnesium as predictor of nephrolithiasis in patients with asymptomatic primary hyperparathyroidism
Sun 19 12:24
OC1.3
Oral Communications 1: Calcium and Bone
MENIN AND EZH2 ACTIVITIES MODULATE THE EXPRESSION OF THE LONG NON-CODING RNA HAR1B IN PARATHYROID TUMORS
Sun 19 12:36
OC1.4
Oral Communications 1: Calcium and Bone
Risk of Sepsis, Respiratory Infections, and Kidney or Other Genitourinary (GU) Infections in Patients with Chronic Hypoparathyroidism (HypoPT): A Retrospective Cohort Study
Sun 19 12:48
OC1.5
Oral Communications 1: Calcium and Bone
Renal Function in 711 patients with Hypoparathyroidism during more than 4 years of therapy
Sun 19 12:00
Oral Communications 2: Diabetes 1
Forum 2
Chairs: Hubert Vidal (France) & Bruno Verges (France)
Sun 19 12:00
OC2.1
Oral Communications 2: Diabetes 1
EVERY FIFTH PATIENT WITH TYPE 1 DIABETES SUFFERS FROM AN ADDITIONAL ENDOCRINOLOGICAL AUTOIMMUNE DISEASE – A FINNISH NATIONWIDE STUDY
Sun 19 12:12
OC2.2
Oral Communications 2: Diabetes 1
Elevated glucose uptake in skeletal muscle with increased sarcolemma translocation of GLUT4 and glycogen synthesis contributes to bariatric surgery mediated diabetes remission
Sun 19 12:24
OC2.3
Oral Communications 2: Diabetes 1
Identification of oxygen-18 isotope of breath carbon dioxide as a non-invasive marker to distinguish type 1 and type 2 diabetes
Sun 19 12:36
OC2.4
Oral Communications 2: Diabetes 1
Empagliflozin attenuates the progression of atherosclerosis in APO-E knockout mice
Sun 19 12:48
OC2.5
Oral Communications 2: Diabetes 1
5β-reductase (AKR1D1) deletion drives hepatic inflammation, fibrosis and tumour development in vitro and in vivo
Mon 20 12:00
Oral Communications 8: Reproduction 1
Forum 1
Chairs: Victor Navarro (USA) & Nadine Binart (France)
Mon 20 12:00
OC8.1
Oral Communications 8: Reproduction 1
Dissecting the roles of KNDy-derived kisspeptins in the control of reproduction: Generation and characterization of the Tac2-specific Kiss1 KO (TaK-KO) mouse
Mon 20 12:12
OC8.2
Oral Communications 8: Reproduction 1
AMH is a predictive factor for successful sperm retrieval in non-mosaic Klinefelter syndrome patients
Mon 20 12:24
OC8.3
Oral Communications 8: Reproduction 1
Endocrine Disruptors transgenerationally alters pubertal timing through epigenetic reprogramming of the hypothalamus.
Mon 20 12:36
OC8.4
Oral Communications 8: Reproduction 1
Conditional ablation of AMP-Activated Protein Kinase (AMPK) in GnRH Neurons Reveals Specific Roles in Reproductive and Metabolic Homeostasis
Mon 20 12:48
OC8.5
Oral Communications 8: Reproduction 1
The Neurokinin 3 Receptor Antagonist, Fezolinetant, Is Effective in Treatment of Menopausal Vasomotor Symptoms: Responder Analysis Results From a Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Study
Tue 21 11:30
Oral Communications 10: Adrenal 1
Forum 2
Chairs: Attila Patocs (Hungary) & Jerome Bertherat (France)
Tue 21 11:30
OC10.1
Oral Communications 10: Adrenal 1
Steroid Metabolomics: A Rapid Computational Approach for Accurate Differentiation of Inborn Disorders of Steroidogenesis.
Tue 21 11:42
OC10.2
Oral Communications 10: Adrenal 1
Glucocorticoid resistance patients exhibit defective cortisol metabolism, responsible for functional hypermineralocorticism
Tue 21 11:54
OC10.3
Oral Communications 10: Adrenal 1
Genetic predisposition to Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH): next generation sequencing ARMC5, NR3C1 (Glucocorticoid Receptor) and PDE11A4 (Phosphodiesterase 11) in 389 patients
Tue 21 12:06
OC10.4
Oral Communications 10: Adrenal 1
Cullin 3 is a partner of Armadillo Repeat Containing 5 (ARMC5), the product of the gene responsible for Primary Bilateral Macronodular Adrenal Hyperplasia
Tue 21 12:18
OC10.5
Oral Communications 10: Adrenal 1
Cyclin Dependent Kinase 4 as promising drug target in adrenocortical carcinoma
Birmingham, United Kingdom
Expert 31
Sun 19 08:00
Meet The Expert 1: Diabetes, Obesity and Metabolism
Forum 3
Diabetes, Obesity and Metabolism
Sun 19 08:00
MTE1
Meet The Expert 1: Diabetes, Obesity and Metabolism
The road from flash and continuous glucose monitoring towards closed loop systems in diabetes
Sun 19 08:00
Meet The Expert 2: Diabetes, Obesity and Metabolism
Auditorium Lumière
Diabetes, Obesity and Metabolism
Sun 19 08:00
MTE2
Meet The Expert 2: Diabetes, Obesity and Metabolism
Long-term endocrine-metabolic effects of bariatric surgery: do the benefits really outweigh the risks?
Sun 19 08:00
Meet The Expert 3: Adrenal and Neuroendocrine Tumours
Forum 2
Adrenal and Neuroendocrine Tumours
Sun 19 08:00
MTE3
Meet The Expert 3: Adrenal and Neuroendocrine Tumours
The management of primary aldosteronism
Sun 19 08:00
Meet The Expert 4: Adrenal and Neuroendocrine Tumours
Salle Gratte-Ciel 1+2+3
Adrenal and Neuroendocrine Tumours
Sun 19 08:00
MTE4
Meet The Expert 4: Adrenal and Neuroendocrine Tumours
Management of a life-long disease in CAH
Munich, Germany
Sun 19 08:00
Meet The Expert 5: Thyroid
L'Amphithéâtre
Thyroid
Sun 19 08:00
MTE5
Meet The Expert 5: Thyroid
Risk classification of thyroid nodules by ultrasound and indications for FNA
Sun 19 08:00
Meet The Basic Scientist 1: Interdisciplinary Endocrinology
Forum 1
Interdisciplinary Endocrinology
Sun 19 08:00
MTBS1
Meet The Basic Scientist 1: Interdisciplinary Endocrinology
New tracers for PET in humans and rodents: Hopes, aims and current evidence
Sun 19 12:00
Controversies Session: Food addiction in humans: to be or not to be?
L'Amphithéâtre
Chairs: Uberto Pagotto (Italy) & Gatta-Cherifi Blandine (France)
Interdisciplinary Endocrinology
Sun 19 12:00
C1.1
Controversies Session: Food addiction in humans: to be or not to be?
Food addiction in humans: to be or not to be?
Sun 19 14:00
New Scientific Approach 1
Forum 3
Chair: Matti Poutanen (Finland)
Sun 19 14:00
NSA1
New Scientific Approach 1
Steroidomics
Giessen, Germany
Sun 19 14:00
New Scientific Approach 2
Auditorium Lumière
Chair: Agnieszka Piekielko-Witkowska (Poland)
Sun 19 14:00
NSA2
New Scientific Approach 2
Single cell spatial reconstruction of endocrine organs
Sun 19 15:15
Debate 1: Surgical treatment of phaeochromocytoma - query pre-treatment?
Auditorium Lumière
Chairs: Massimo Mannelli (Italy) & Frederic Castinetti (France)
Adrenal and Neuroendocrine Tumours
Sun 19 15:15
D1.1
Debate 1: Surgical treatment of phaeochromocytoma - query pre-treatment?
FOR: Surgical treatment of phaeochromocytoma - query pre-treatment?
Nijmegen, The Netherlands
Sun 19 15:15
D1.2
Debate 1: Surgical treatment of phaeochromocytoma - query pre-treatment?
AGAINST: Surgical treatment of phaeochromocytoma - query pre-treatment?
Essen, Germany
Mon 20 08:00
Meet The Expert 6: Calcium and Bone
Forum 3
Calcium and Bone
Mon 20 08:00
MTE6
Meet The Expert 6: Calcium and Bone
Primary Hyperparathyroidism: Surgical vs Medical Therapy
Mon 20 08:00
Meet The Expert 7: Pituitary and Neuroendocrinology
L'Amphithéâtre
Pituitary and Neuroendocrinology
Mon 20 08:00
MTE7
Meet The Expert 7: Pituitary and Neuroendocrinology
Non functional Pituitary Tumours - not always easy
Mon 20 08:00
Meet The Expert 8: Reproductive Endocrinology
Auditorium Lumière
Reproductive Endocrinology
Mon 20 08:00
MTE8
Meet The Expert 8: Reproductive Endocrinology
Co-morbidities in Turner syndrome
Mon 20 08:00
Meet The Expert 9: Reproductive Endocrinology
Forum 2
Reproductive Endocrinology
Mon 20 08:00
MTE9
Meet The Expert 9: Reproductive Endocrinology
Co-morbidities in Klinefelter syndrome
Mon 20 08:00
Meet The Expert 10: Reproductive Endocrinology
Forum 1
Reproductive Endocrinology
Mon 20 08:00
MTE10
Meet The Expert 10: Reproductive Endocrinology
NCAH and Female reproduction
Mon 20 08:00
Meet The Basic Scientist 2
Salle Gratte-Ciel 1+2+3
Mon 20 08:00
MTBS2
Meet The Basic Scientist 2
Genetically tailored pig models in translational endocrine and metabolic research
Mon 20 10:20
Debate 2: T4 is not enough
L'Amphithéâtre
Chairs: Robin Peeters (The Netherlands) & Patrice Rodien (France)
Thyroid
Mon 20 10:20
D2.2
Debate 2: T4 is not enough
AGAINST: No, T4 is enough
Mon 20 10:20
D2.1
Debate 2: T4 is not enough
FOR: Yes, T4 is not enough
Mon 20 12:00
Debate 3: Pituitary Pathology: Do we care?
L'Amphithéâtre
Chairs: Gerald Raverot (France) & Jens Otto Jorgensen (Denmark)
Pituitary and Neuroendocrinology
Mon 20 12:00
D3.1
Debate 3: Pituitary Pathology: Do we care?
FOR: Yes, we care about pituitary pathology
Mon 20 12:00
D3.2
Debate 3: Pituitary Pathology: Do we care?
AGAINST: No, we don't care about pituitary pathology
Mon 20 14:00
New Scientific Approach 3
Salle Gratte-Ciel 1+2+3
Chair: Guillaume Assie (France)
Mon 20 14:00
NSA3
New Scientific Approach 3
Intelligent image based in situ single cell isolation
Mon 20 14:00
New Scientific Approach 4
Forum 1
Chair: Vera Popovic (Serbia)
Mon 20 14:00
NSA4
New Scientific Approach 4
When will AI take over from the endocrinologist?
Tue 21 08:00
Meet The Expert 11: Calcium and Bone
Forum 2
Calcium and Bone
Tue 21 08:00
MTE11
Meet The Expert 11: Calcium and Bone
Shifting treatment paradigms in osteoporosis
Tue 21 08:00
Meet The Expert 12: Calcium and Bone
Forum 1
Calcium and Bone
Tue 21 08:00
MTE12
Meet The Expert 12: Calcium and Bone
Fracture risk prediction in benign and tumoral bone: new insights
Tue 21 08:00
Meet The Expert 13: Interdisciplinary Endocrinology
Forum 3
Interdisciplinary Endocrinology
Tue 21 08:00
MTE13
Meet The Expert 13: Interdisciplinary Endocrinology
Flushing, blushing and sweating
Tue 21 08:00
Meet The Expert 14: Interdisciplinary Endocrinology
Salle Gratte-Ciel 1+2+3
Interdisciplinary Endocrinology
Tue 21 08:00
MTE14
Meet The Expert 14: Interdisciplinary Endocrinology
How multidisciplinary care and tailor-made transition save lives of young adults with Prader-Willi syndrome
Tue 21 08:00
Meet The Expert 15: Pituitary and Neuroendocrinology
L'Amphithéâtre
Pituitary and Neuroendocrinology
Tue 21 08:00
MTE15
Meet The Expert 15: Pituitary and Neuroendocrinology
To what degree does hypopituitarism exist after TBI?
Tue 21 08:00
Meet The Expert 16: Interdisciplinary Endocrinology
Auditorium Lumière
Interdisciplinary Endocrinology
Tue 21 08:00
MTE16.2
Meet The Expert 16: Interdisciplinary Endocrinology
Is it all in your head or just in the lab?
Tue 21 08:00
MTE16.1
Meet The Expert 16: Interdisciplinary Endocrinology
Is it all in your head or just in the lab?
Tue 21 08:00
Meet The Basic Scientist 3
Salon Prestige Gratte-Ciel
Tue 21 08:00
MTBS3
Meet The Basic Scientist 3
The “Gravitostat” – How does it relate to hormones?
Tue 21 09:50
Debate 4: MicroRNAs as hormones?
Salle Gratte-Ciel 1+2+3
Chairs: Peter Igaz (Hungary) & Attila Patócs (Hungary)
Interdisciplinary Endocrinology
Tue 21 09:50
D4.2
Debate 4: MicroRNAs as hormones?
AGAINST: MicroRNAs as hormones?
Tue 21 09:50
D4.1
Debate 4: MicroRNAs as hormones?
FOR: MicroRNAs and extracellular vesicles as hormones?
Tue 21 13:30
New Scientific Approach 5
Forum 1
Chair: Cristina Olarescu (Norway)
Tue 21 13:30
NSA5
New Scientific Approach 5
Genome-wide effects of vitamin D on chromatin
Tue 21 13:30
New Scientific Approach 6
Forum 2
Chair: Patrice Mollard (France)
Tue 21 13:30
NSA6
New Scientific Approach 6
Brain imaging in conscious mice
Tue 21 14:30
Debate 5: Should we treat young osteoporotic patients
L'Amphithéâtre
Chairs: Gesthimani Mintziori (Greece) & Carola Zillikens (The Netherlands)
Calcium and Bone
Tue 21 14:30
D5.2
Debate 5: Should we treat young osteoporotic patients
AGAINST: No, we shouldn't treat young osteoporotic patients
Tue 21 14:30
D5.1
Debate 5: Should we treat young osteoporotic patients
FOR: Yes, we should treat young osteoporotic patients
Plenary 11
Sat 18 17:45
Plenary: Geoffrey Harris Award Lecture
L'Amphithéâtre
Chairs: AJ van der Lely (The Netherlands) & Monica Marazuela (Spain)
Sat 18 17:45
GH1
Plenary: Geoffrey Harris Award Lecture
Translational research in pituitary disease
Sat 18 18:20
Plenary: European Journal of Endocrinology Award Lecture
L'Amphithéâtre
Chairs: Wiebke Arlt (UK) & AJ van der Lely (The Netherlands)
Sat 18 18:20
EJE1
Plenary: European Journal of Endocrinology Award Lecture
New approaches in the differential diagnosis of Diabetes insipidus
Basel, Switzerland
Sat 18 19:00
Plenary 1
L'Amphithéâtre
Chairs: Marta Korbonits (UK) & Sebastian Neggers (The Netherlands)
Sat 18 19:00
PL1
Plenary 1
Designing Cities and Homes as Exercise Machines: Helping endocrinologists to fight metabolic disease
Sun 19 09:20
Plenary 2
ENDORSED BY: EJE (European Journal of Endocrinology)
L'Amphithéâtre
Chairs: Manuel Tena-Sempere (Spain) & Csilla Krausz (Italy)
PL2
Sun 19 09:20
PL2
Plenary 2
Genetic epidemiology of puberty timing and reproductive lifespan
Cambridge, United Kingdom
Sun 19 17:00
Plenary 3
L'Amphithéâtre
Chairs: Bulent Yildiz (Turkey) & Anton Luger (Austria)
Sun 19 17:00
PL3
Plenary 3
Pancreatic beta-cell ageing: Novel mechanisms and consequences in the management of diabetes
Mon 20 08:50
Plenary 4
L'Amphithéâtre
Chairs: Camilla Schalin-Jäntti (Finland) & Beata Kos-Kulda (Poland)
Mon 20 08:50
PL4
Plenary 4
Exercise training in the management of T2D
Mon 20 09:20
Plenary: European Hormone Medal Lecture
L'Amphithéâtre
Chairs: Djuro Macut (Serbia) & Andrea Giustina (Italy)
Mon 20 09:20
EHM1
Plenary: European Hormone Medal Lecture
Monogenic Bone Disorders as a Model for Novel Treatment of Osteoporosis
Mon 20 16:50
Plenary: Clinical Endocrinology Trust Lecture
L'Amphithéâtre
Chairs: Jerome Bertherat (France) & Wiebke Arlt (UK)
Mon 20 16:50
CET1
Plenary: Clinical Endocrinology Trust Lecture
How can patients perception of outcome be improved after controlling pituitary disease?
Barcelona, Spain
Mon 20 17:20
Plenary 5
L'Amphithéâtre
Chairs: Felix Beuschlein (Germany) & Françoise Borson-Chazot (France)
Mon 20 17:20
PL5
Plenary 5
Paracrine regulation of the adrenal cortex
Tue 21 08:50
Plenary 6
L'Amphithéâtre
Chairs: Claudio Marcocci (Italy) & Jacque Orgiazzi (France)
Tue 21 08:50
PL6
Plenary 6
Treatment strategies for Graves orbitopathy
Mianz, Germany
Tue 21 17:00
Plenary 7
L'Amphithéâtre
Chairs: Riccarda Granata (Italy) & Daniela Cota (France)
Tue 21 17:00
PL7
Plenary 7
Diving into the brain basis of obesity/brain/periphery cross-talk in the regulation of peripheral metabolism
Catering and Social 10
Sun 19 09:50
Tea & Coffee
Exhibition area
Sun 19 13:00
Lunch & Poster viewing
Exhibition area
Sun 19 13:00
Nurses Textbook Launch, Lunch and Informal Networking
ECE Hub
Sun 19 16:30
Tea & Coffee
Exhibition area
Mon 20 09:50
Tea & Coffee
Exhibition area
Mon 20 13:00
Lunch & Poster viewing
Exhibition area
Mon 20 13:00
Nurses Poster Viewing and Presentations, Lunch and Informal Networking
Salon Prestige Gratte-Ciel
Tue 21 09:20
Tea & Coffee
Exhibition area
Tue 21 12:30
Lunch & Poster viewing
Exhibition area
Tue 21 16:00
Tea & Coffee
Exhibition area
Nurse 4
Sun 19 10:20
Nurses Session 1: Immuno-oncology (IO) meets Endocrinology
Salon Prestige Gratte-Ciel
Chairs: Niki Karavitaki (UK) & Chona Feliciano (UK)
Sun 19 10:20
NS1.1
Nurses Session 1: Immuno-oncology (IO) meets Endocrinology
Overview of Immunotherapy: Indications and adverse effects
Sun 19 10:55
NS1.2
Nurses Session 1: Immuno-oncology (IO) meets Endocrinology
Immunotherapy-induced Endocrinopathies: Assessment, Management and Monitoring
London, UK
Sun 19 11:30
NS1.3
Nurses Session 1: Immuno-oncology (IO) meets Endocrinology
The Role of the Endocrine Nurse in Managing Patients with Immunotherapy-induced Endocrinopathies
Birmingham, UK
Sun 19 12:00
Nurses Session 2: Meet the Nurse Expert
Salon Prestige Gratte-Ciel
Chairs: Sherwin Criseno (UK) & Janina Sauerwald (Germany)
Sun 19 12:00
MTNE1
Nurses Session 2: Meet the Nurse Expert
Nursing Approach To The Holistic Care of Patients with Intellectual Disability
Sun 19 15:00
Nurses Session 3: Professional Development
Salon Prestige Gratte-Ciel
Chairs: Sofia Llahana (UK) & Sherwin Criseno (UK)
Sun 19 15:00
NPD1.1
Nurses Session 3: Professional Development
Update from the ESE Nurses Working Group, future projects and presentation of Poster Awards
London, UK
Sun 19 15:30
NPD1.2
Nurses Session 3: Professional Development
2018 Poster Award Presentation: Testosterone replacement: 'The best practice' and the role of the Endocrine Nurse
London, UK
Sun 19 15:45
NPD1.5
Nurses Session 3: Professional Development
Parallel Workshops - How to use the Textbook in Advanced Endocrine Nursing and Competency Framework to develop your clinical practice (Acromegaly)
USA), Lisa Shepherd
Sun 19 15:45
NDP1.4
Nurses Session 3: Professional Development
Parallel Workshops - MY DIABBY – Improving skills and competence in diabetes education
Sun 19 15:45
NPD1.3
Nurses Session 3: Professional Development
Parallel Workshops - How to use the Textbook in Advanced Endocrine Nursing and Competency Framework to develop your clinical practice (Adrenal Insufficiency)
London, UK
Mon 20 10:20
Nurses Session 4: Parathyroid Disorders
Salon Prestige Gratte-Ciel
Chairs: Zaki Hassan-Smith (UK) & Maria Pedersen (Sweden)
Mon 20 10:20
NPD2.1
Nurses Session 4: Parathyroid Disorders
Hypoparathyroidism: Aetiology, diagnosis and challenges in management
Mon 20 10:55
NPD2.2
Nurses Session 4: Parathyroid Disorders
Hyperparathyroidism: Evidence-based screening and management
Dublin, Ireland
Mon 20 11:30
NPD2.3
Nurses Session 4: Parathyroid Disorders
Parathyroid Surgery: Indications and Consequences
Other 17
Sat 18 12:00
REGISTRATION
Sat 18 17:00
ECE 2019 Opening Ceremony
L'Amphithéâtre
Sat 18 19:30
Welcome Reception
Exhibition area
Sun 19 07:00
REGISTRATION
Sun 19 08:00
Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
Salon Prestige Gratte Ciel
Chairs: AJ van der Lely (The Netherlands) & Andrea Giustina (Italy)
PEM1
Sun 19 08:00
PEM1.1
Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
Introduction: Why Policy and Advocacy matters, also to endocrinology - Includes methodology, response, demographics
Sun 19 08:05
PEM1.2
Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
The clinical view of Endocrinology in Europe
France
Sun 19 08:15
PEM1.3
Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
The research view of Endocrinology in Europe
Zürich, Switzerland
Sun 19 08:25
PEM1.4
Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
The early-career perspective
Sun 19 08:35
PEM1.5
Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
Closing remarks and discussion
Sun 19 08:50
Interview with the ESE President and President-Elect
L'Amphithéâtre
Sun 19 12:00
ESE Council of Affiliated Societies Session
Auditorium Lumiere
Chairs: Djuro Macut (Serbia) & Bulent Yildiz (Turkey)
Sun 19 12:00
ECAS1.1
ESE Council of Affiliated Societies Session
Mapping Endocrinology in Europe - ECAS report
Sun 19 12:20
ECAS1.2
ESE Council of Affiliated Societies Session
Centres of special interest - how could we move on?
Sun 19 12:40
ECAS1.3
ESE Council of Affiliated Societies Session
3rd Early Career Clinical Endocrinologist session at EndoBridge 2019 - referring of a patient from primary care to the endocrinology unit
Mon 20 07:00
REGISTRATION
Mon 20 13:00
ESE President meets new members
Mon 20 15:00
Guidelines Session: ESE Clinical Practice Guidelines on the Endocrine Work-up in Obesity
Auditorium Lumière
Chair: Michel Pugeat (France)
Mon 20 15:00
GS1
Guidelines Session: ESE Clinical Practice Guidelines on the Endocrine Work-up in Obesity
Topics: 'Hormonal alterations in obesity', 'Thyroid dysfunction', 'Hypercortisolism', 'Gonadal dysfunction' & 'cther hormones'
Tue 21 07:00
REGISTRATION
Tue 21 09:50
Symposium 25: Late breaking
L'Amphithéâtre
Chairs: Sebastian Neggers (The Netherlands) & Manuel Tena-Sempere (Spain)
Tue 21 09:50
S25.1
Symposium 25: Late breaking
Liver Stress kinases – crossroad between obesity and liver cancer (Source paper: Nature 2019)
Tue 21 10:20
S25.2
Symposium 25: Late breaking
LT4 treatment and pregnancy outcomes in TPOab positive women: results of the TABLET Trial
Tue 21 10:50
S25.3
Symposium 25: Late breaking
Maternal smoking and high BMI disrupt thyroid gland development
Tue 21 09:50
Publishing Session
Salon Prestige Gratte-Ciel
Chair: Beata Kos-Kulda (Poland)
Tue 21 09:50
PS1.1
Publishing Session
Endocrine Connections - ‘Increase the visibility of your research: open access and more’
Tue 21 10:20
PS1.2
Publishing Session
EDM Case Reports - ‘Top tips for writing and submitting an article – an early career researcher’s perspective’
Tue 21 10:50
PS1.3
Publishing Session
European Journal of Endocrinology - ‘Common methodological flaws and how to avoid them’
Tue 21 11:30
UEMS Session
Forum 3
Chairs: Maeve Durkan (Republic of Ireland) & Teri Brouwer (The Netherlands)
Tue 21 11:30
UEMS1.2
UEMS Session
Update on European Exam in Endocrinology
Waterford, Ireland
Tue 21 11:45
UEMS1.1
UEMS Session
The role of UEMS in Europe and the distinct and independent but allied pathway with ESE
Tue 21 12:00
UEMS1.3
UEMS Session
The microenvironment of pituitary neuroendocrine tumors: focus on folliculostellate cells
Tue 21 12:45
ESE Annual General Meeting
Tue 21 16:30
ESE Young Investigator Awards and Jens Sandahl Christansen Awards Ceremony
L'Amphithéâtre
Chairs: Manuel Tena-Sempere (Spain) & Sebastian Neggers (The Netherlands) & Françoise Borson-Chazot (France)
Tue 21
EYIJC1
ESE Young Investigator Awards and Jens Sandahl Christansen Awards Ceremony
The metabolic effects of SGLT2 inhibitors – Does the increase in ketone bodies protect the heart?
Tue 21
EYIJC2
ESE Young Investigator Awards and Jens Sandahl Christansen Awards Ceremony
Role of hypothalamic AMP-activated protein kinase (AMPK) in the central regulation of energy balance
Tue 21 17:30
Closing Ceremony
L'Amphithéâtre
Symposium 34
Sun 19 10:20
Symposium 1: Thyroid in cancer
Forum 3
Chairs: Barbara Jarzab (Poland) & Sophie Leboulleux (France)
Thyroid
Sun 19 10:20
S1.1
Symposium 1: Thyroid in cancer
What is the value of molecular markers in nodules
Sun 19 10:50
S1.2
Symposium 1: Thyroid in cancer
Iodine refractoriness in thyroid cells
Birmingham, UK
Sun 19 11:20
S1.3
Symposium 1: Thyroid in cancer
New paradigms in the treatment of low risk thyroid cancer
Sun 19 10:20
Symposium 2: Trends in Puberty
Forum 2
Chairs: Carlo Acerini (UK) & Vincent Prevot (France)
Reproductive Endocrinology
Sun 19 10:20
S2.1
Symposium 2: Trends in Puberty
Exploring the Epigenetic Landscape of Puberty
Sun 19 10:50
S2.2
Symposium 2: Trends in Puberty
Endocrine disruptors in puberty
Liège, Belgium
Sun 19 11:20
S2.3
Symposium 2: Trends in Puberty
Genetic basis in puberty
London, UK
Sun 19 10:20
Symposium 3: Circadian clocks: from pathophysiology to chronomedicine
Salle Gratte-Ciel 1+2+3
Chairs: Ashley Grossman (UK) & Gudmundur Johannsson (Sweden)
Interdisciplinary Endocrinology
Sun 19 10:20
S3.1
Symposium 3: Circadian clocks: from pathophysiology to chronomedicine
Circadian control of glucocorticoid function
Manchester, UK
Sun 19 10:50
S3.2
Symposium 3: Circadian clocks: from pathophysiology to chronomedicine
Fixing the Broken Clock in Adrenal Disorders
Sapienza University of Rome, Italy
Sun 19 11:20
S3.3
Symposium 3: Circadian clocks: from pathophysiology to chronomedicine
Light Up Your Sex Life!
Sun 19 10:20
Symposium 4: Immunology and endocrinology
ENDORSED BY: EC (Endocrine Connections)
Forum 1
Chairs: Sandra Pekic (Serbia) & Simon Pearce (UK)
Interdisciplinary Endocrinology
Sun 19 10:50
S4.2
Symposium 4: Immunology and endocrinology
Clinical: Immunotherapy and endocrine disease
Sun 19 11:00
S4.3
Symposium 4: Immunology and endocrinology
Transitional: The diagnostic value of autoimmune antibodies in endocrine disorders
Stockholm, Sweden
Sun 19 11:20
S4.1
Symposium 4: Immunology and endocrinology
Basic: Immunotherapy and endocrine disease
Sun 19 10:20
Symposium 5: Microbiota as new treatment for diabetes and metabolic disease
L'Amphithéâtre
Chairs: Anton Luger (Austria) & Ioannis Androulakis (Greece)
Diabetes, Obesity and Metabolism
Sun 19 10:20
S5.1
Symposium 5: Microbiota as new treatment for diabetes and metabolic disease
Human gut microbiome: hopes, threats and promises
Sun 19 10:50
S5.2
Symposium 5: Microbiota as new treatment for diabetes and metabolic disease
Fecal transplantation: Myth or reality
Sun 19 11:20
S5.3
Symposium 5: Microbiota as new treatment for diabetes and metabolic disease
Targeted Microbiome Intervention for handling insulin resistance
Sun 19 10:20
Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - OK, so that’s why; more insight into the ins and outs of obesity - 4th Joint Global Symposium on Obesity
Auditorium Lumière
Chairs: AJ van der Lely (The Netherlands) & Jenny Visser (The Netherlands) & Andre Lacroix (Canada)
Sun 19 10:20
SS1.1
Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - OK, so that’s why; more insight into the ins and outs of obesity - 4th Joint Global Symposium on Obesity
Obesity gives you cancer: the bigger picture!
Sun 19 10:50
SS1.2
Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - OK, so that’s why; more insight into the ins and outs of obesity - 4th Joint Global Symposium on Obesity
Sleep Deficiency: A Pathway to Obesity
Sun 19 11:20
SS1.3
Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - OK, so that’s why; more insight into the ins and outs of obesity - 4th Joint Global Symposium on Obesity
Social economic impact of the globesity pandemic
Sun 19 13:45
Industry Sponsored Satellite Symposium
Forum 2
Sun 19 15:00
Symposium 6: A better life with thyroid hormone
ENDORSED BY: EJE (European Journal of Endocrinology)
L'Amphithéâtre
Chairs: Emese Mezosi (Hungary) & Ulla Feldt-Rasmussen (Denmark)
Thyroid
Sun 19 15:00
S6.1
Symposium 6: A better life with thyroid hormone
Prediction of the thyroid axis set-point
Sun 19 15:30
S6.2
Symposium 6: A better life with thyroid hormone
Subclinical hypothyroidism in children
Sun 19 16:00
S6.3
Symposium 6: A better life with thyroid hormone
Subclinical hypothyroidism in the elderly
Newcastle, UK
Sun 19 15:00
Symposium 7: Endocrine Disrupting Chemicals
ENDORSED BY: EC (Endocrine Connections)
Forum 3
Chairs: Josef Koehrle (Germany) & Anne-Simone Parent (Belgium)
Environmental, Society and Governance
Sun 19 15:00
S7.1
Symposium 7: Endocrine Disrupting Chemicals
Endocrine Disrupting Chemicals and Thyroid
Sun 19 15:30
S7.2
Symposium 7: Endocrine Disrupting Chemicals
Endocrine Disrupting Chemicals and Diabetes Mellitus
Sun 19 16:00
S7.3
Symposium 7: Endocrine Disrupting Chemicals
Endocrine Disrupting Chemicals and Obesity
Sun 19 15:00
Symposium 8: Gender dysphoria
Salle Gratte-Ciel 1+2+3
Chairs: Feyza Darendeliler (Turkey) & Luca Persani (Italy)
Interdisciplinary Endocrinology
Sun 19 15:00
S8.1
Symposium 8: Gender dysphoria
Psychoendocrinology Of Gender Dysphoria
Sun 19 15:30
S8.2
Symposium 8: Gender dysphoria
Gender Dysphoria –management of puberty
Ghent, Belgium
Sun 19 16:00
S8.3
Symposium 8: Gender dysphoria
Gender reassignment surgery in dysphoria
Sun 19 15:00
Symposium 9: Controversies in adrenal disease
Forum 2
Chairs: Judith Favier (France) & Daniel Olsson (Sweden)
Adrenal and Neuroendocrine Tumours
Sun 19 15:00
S9.3
Symposium 9: Controversies in adrenal disease
Is there a role for subtotal adrenalectomy
Sun 19 15:30
S9.1
Symposium 9: Controversies in adrenal disease
Metanephrines - plasma or urine?
Dresden , Germany
Sun 19 16:00
S9.2
Symposium 9: Controversies in adrenal disease
The do's and don'ts of genetic testing in phaeochromocytoma
Sun 19 15:00
Symposium 10: Cancer drug-induced osteoporosis
ENDORSED BY: EC (Endocrine Connections)
Forum 1
Chairs: Martine Cohen-Solal (France) & Carola Zillikens (The Netherlands)
Calcium and Bone
Sun 19 15:00
S10.1
Symposium 10: Cancer drug-induced osteoporosis
Mechanisms of skeletal metastasis (could be induced by breast cancer or prostate cancer or both)
Dresden, Germany
Sun 19 15:30
S10.2
Symposium 10: Cancer drug-induced osteoporosis
Aromatase inhibitors and bone
Sun 19 16:00
S10.3
Symposium 10: Cancer drug-induced osteoporosis
TSH-suppressive therapy and bone
Sun 19 17:45
Industry Sponsored Satellite Symposium
Forum 1
Mon 20 10:20
Symposium 11: EDCs and reproduction
Forum 3
Chairs: Rachel Desailloud (France) & Anna-Maria Andersson (Denmark)
Environmental, Society and Governance
Mon 20 10:20
S11.1
Symposium 11: EDCs and reproduction
Oocytes, Pesticides and IVF
Mon 20 10:50
S11.2
Symposium 11: EDCs and reproduction
Testicular germ cell cancer: role of fœtal exposure to endocrine disruptors
Mon 20 11:20
S11.3
Symposium 11: EDCs and reproduction
Mitigating against endocrine disruption in pregnancy
Copenhagen, Denmark
Mon 20 10:20
Symposium 12: Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
Forum 1
Chairs: Michael Buchfelder (Germany) & Cesar Boguszewski (Brazil)
Pituitary and Neuroendocrinology
Mon 20 10:20
S12.1
Symposium 12: Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
The view of the surgeon: When, how much and when to refrain from surgery?
Mon 20 10:50
S12.2
Symposium 12: Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
New potential treatment alternatives in patients with papillary craniopharyngioma
Mon 20 11:20
S12.3
Symposium 12: Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
How to manage the long-term consequences of hypothalamic damages
Mon 20 10:20
Symposium 13: Central Control of Metabolism: Brain rules all
Salle Gratte-Ciel 1+2+3
Chairs: Johannes Romijn (The Netherlands) & Ivana Kraljevic (Croatia)
Diabetes, Obesity and Metabolism
Mon 20 10:20
S13.1
Symposium 13: Central Control of Metabolism: Brain rules all
All optics in the metabolic brain
Mon 20 10:50
S13.2
Symposium 13: Central Control of Metabolism: Brain rules all
Role of mitochondria/cell bioenergetics in CNS regulation of energy balance
Mon 20 11:20
S13.3
Symposium 13: Central Control of Metabolism: Brain rules all
Genetics of appetite regulation
Cambridge, UK
Mon 20 10:20
Symposium 14: Innovations in NETs
Auditorium Lumière
Chairs: Diego Ferone (Italy) & Mehtap Cakir (Turkey)
Adrenal and Neuroendocrine Tumours
Mon 20 10:20
S14.1
Symposium 14: Innovations in NETs
Innovative imaging of insulinoma: The end of sampling…
Mon 20 10:50
S14.2
Symposium 14: Innovations in NETs
A role for radionuclide therapy for high-grade NETs
Mon 20 11:20
S14.3
Symposium 14: Innovations in NETs
Fishing for NETs
Mon 20 10:20
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Forum 2
Chairs: Peter Aldiss (UK) & Thomas Cuny (France)
Organ cross-talk in endocrine disease
Mon 20 10:20
S15.1
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Welcome and Introduction to EYES
Mon 20 10:25
S15.2
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Investigating glucocorticoids as the mechanism behind bone marrow adiposity expansion during caloric restriction
Mon 20 10:45
S15.3
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Role of hypothalamic bile acid-TGR5 signaling in the regulation of energy balance
Mon 20 11:05
S15.4
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
The role and cross-talk between incretin hormones and occurrence of Nonalcoholic steatohepatitis
Mon 20 11:25
S15.5
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Lysophosphatidic acid in pathogenesis of HNF1B-MODY syndrome
Mon 20 11:45
S15.6
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Closing remarks
Mon 20 13:45
Industry Sponsored Satellite Symposium
Forum 2
Mon 20 15:00
Symposium 16: Thyroid in pregnancy
L'Amphithéâtre
Chairs: Sophie Christin-Maitre (France) & Leonidas Duntas (Greece)
Thyroid
Mon 20 15:00
S16.1
Symposium 16: Thyroid in pregnancy
Thyroid autoimmunity and fertility
Mon 20 15:30
S16.2
Symposium 16: Thyroid in pregnancy
Thyroid disease and pregnancy outcomes
Mon 20 16:00
S16.3
Symposium 16: Thyroid in pregnancy
Thyroid disease and offspring development
Mon 20 15:00
Symposium 17: Where Do Pituitary Tumours Come From
Forum 1
Chairs: Günter K. Stalla (Germany) & Philippe Chanson (France)
Pituitary and Neuroendocrinology
Mon 20 15:00
S17.1
Symposium 17: Where Do Pituitary Tumours Come From
Specification of cell fate
Montreal, Canada
Mon 20 15:30
S17.2
Symposium 17: Where Do Pituitary Tumours Come From
Pertubations in novel signalling pathways
London, UK
Mon 20 16:00
S17.3
Symposium 17: Where Do Pituitary Tumours Come From
From Lab to Clinic - Can we translate into effective therapeutics
Paris, France
Mon 20 15:00
Symposium 18: Congenital Hypogonadotropic Hypogonadism: New insights into GnRH Regulation
Salle Gratte-Ciel 1+2+3
Chairs: Ursula Kaiser (USA) & Nelly Pitteloud (Switzerland)
Reproductive Endocrinology
Mon 20 15:00
S18.1
Symposium 18: Congenital Hypogonadotropic Hypogonadism: New insights into GnRH Regulation
GnRH migration and vomeronasal neurons
Mon 20 15:30
S18.2
Symposium 18: Congenital Hypogonadotropic Hypogonadism: New insights into GnRH Regulation
Flipping the GnRH switch with microRNAs
Mon 20 16:00
S18.3
Symposium 18: Congenital Hypogonadotropic Hypogonadism: New insights into GnRH Regulation
Congenital Hypogonadotropic Hypogonadism: Clinical Perspectives
Mon 20 15:00
Symposium 19: Adrenal Insufficiency
Forum 2
Chairs: Antoine Tabarin (France) & Thierry Brue (France)
Adrenal and Neuroendocrine Tumours
Mon 20 15:00
S19.1
Symposium 19: Adrenal Insufficiency
New insights into autoimmune adrenal insufficiency

Unknown speaker

Bergen, Norway
Mon 20 15:30
S19.2
Symposium 19: Adrenal Insufficiency
Long-term results of slow acting glucocorticoids - are they really better?
Mon 20 16:00
S19.3
Symposium 19: Adrenal Insufficiency
Optimising care delivery in Congenital Adrenal Hyperplasia
Sheffield, UK
Mon 20 15:00
Symposium 20: News on Nutrition: When to eat what
Forum 3
Chairs: Bruno Verges (France) & Justo Castaño (Spain)
Diabetes, Obesity and Metabolism
Mon 20 15:00
S20.1
Symposium 20: News on Nutrition: When to eat what
Precision Nutrition for managing obesity – Does it work?
Mon 20 15:30
S20.2
Symposium 20: News on Nutrition: When to eat what
Is limiting the timing of food intake a viable nutritional approach?
Mon 20 16:00
S20.3
Symposium 20: News on Nutrition: When to eat what
PREDIMED Plus trial - energy-restricted Mediterranean diet plus exercise and metabolic health
Mon 20 18:00
Industry Sponsored Satellite Symposium
Salle Gratte-Ciel 1+2+3
Tue 21 09:50
Symposium 21: Rare Bone Disorders
Forum 2
Chairs: Barbara Obermayer-Pietsch (Austria) & Lars Rejmark (Denmark)
Calcium and Bone
Tue 21 09:50
S21.1
Symposium 21: Rare Bone Disorders
Animal model of bone fragility
Pavia, Italy
Tue 21 10:20
S21.2
Symposium 21: Rare Bone Disorders
New perspectives on the treatment of skeletal dysplasia
Paris, France
Tue 21 10:50
S21.3
Symposium 21: Rare Bone Disorders
Osteogenesis imperfecta throughout life
Oxford, UK
Tue 21 09:50
Symposium 22: The Pituitary As Metabolic Sensor
Forum 1
Chairs: Clara Alvarez (Spain) & Agnieszka Baranowska-Bik (Poland)
Pituitary and Neuroendocrinology
Tue 21 09:50
S22.1
Symposium 22: The Pituitary As Metabolic Sensor
Kiss1 as integrator of endocrine and metabolic function in the hypothalamic-pituitary axis
Tue 21 10:20
S22.2
Symposium 22: The Pituitary As Metabolic Sensor
How treatments with endocrine & metabolic drugs influence pituitary cell function?
Tue 21 10:50
S22.3
Symposium 22: The Pituitary As Metabolic Sensor
Bidirectional interrelationship between growth hormone and metabolism
Tue 21 09:50
Symposium 23: PCOS: Can we personalise treatment?
Auditorium Lumière
Chairs: Marija Pfeifer (Slovenia) & Terhi Piltonen (Finland)
Reproductive Endocrinology
Tue 21 09:50
S23.1
Symposium 23: PCOS: Can we personalise treatment?
Gut brain axis
Tue 21 10:20
S23.2
Symposium 23: PCOS: Can we personalise treatment?
Implicating androgen excess in metabolic disease in PCOS

Unknown speaker

Tue 21 10:50
S23.3
Symposium 23: PCOS: Can we personalise treatment?
Treatment options in cardiometabolic PCOS phenotype
Tue 21 09:50
Symposium 24: What's new in the Adrenal Cortex?
ENDORSED BY: EJE (European Journal of Endocrinology)
Forum 3
Chairs: Darko Kastelan (Croatia) & Marc Lombes (France)
Adrenal and Neuroendocrine Tumours
Tue 21 09:50
S24.1
Symposium 24: What's new in the Adrenal Cortex?
New genes, new understanding, new therapy
Tue 21 10:20
S24.2
Symposium 24: What's new in the Adrenal Cortex?
Primary hyperaldosteronism: does our treatment work?
Tue 21 10:50
S24.3
Symposium 24: What's new in the Adrenal Cortex?
Autonomous cortisol secretion has cardiovascular consequences
Tue 21 14:30
Symposium 26: Impact of thyroid disease on...
Auditorium Lumière
Chairs: Marek Ruchala (Poland) & Leonidas Duntas (Greece)
Thyroid
Tue 21 14:30
S26.1
Symposium 26: Impact of thyroid disease on...
Role of thyroid hormones in the pathogenesis and treatment of psychiatric disorders
Tue 21 15:00
S26.2
Symposium 26: Impact of thyroid disease on...
Bone
Tue 21 15:30
S26.3
Symposium 26: Impact of thyroid disease on...
Cardiac hypertrophy
Tue 21 14:30
Symposium 27: What's new in reproductive endocrinology?
Forum 1
Chairs: Jenny Visser (The Netherlands) & Sophie Christin-Maitre (France)
Reproductive Endocrinology
Tue 21 14:30
S27.1
Symposium 27: What's new in reproductive endocrinology?
Dissecting Androgens in PCOS
Tue 21 15:00
S27.2
Symposium 27: What's new in reproductive endocrinology?
Large scale genetic studies in male infertility
Tue 21 15:30
S27.3
Symposium 27: What's new in reproductive endocrinology?
Menopause and cardiovascular risk
Tue 21 14:30
Symposium 28: Vitamin D - non-skeletal effects in RCTs
Salle Gratte-Ciel 1+2+3
Chairs: Bruno Lapauw (Belgium) & Nuria Guanabens (Spain)
Calcium and Bone
Tue 21 14:30
S28.1
Symposium 28: Vitamin D - non-skeletal effects in RCTs
Vitamin D and its metabolites
Tue 21 15:00
S28.2
Symposium 28: Vitamin D - non-skeletal effects in RCTs
Vitamin D and Type 1 Diabetes
Tue 21 15:30
S28.3
Symposium 28: Vitamin D - non-skeletal effects in RCTs
How and when to measure Vitamin D
Tue 21 14:30
Symposium 29: Endocrine controversies in sport
Forum 2
Chairs: Margaret Boguszewski (Brazil) & Martin Bidlingmaier (Germany)
Environmental, Society and Governance
Tue 21 14:30
S29.1
Symposium 29: Endocrine controversies in sport
Female hyperandrogenism and elite sport
Stockholm, Sweden
Tue 21 15:00
S29.2
Symposium 29: Endocrine controversies in sport
Performance enhancing drugs in young males
Tue 21 15:30
S29.3
Symposium 29: Endocrine controversies in sport
Omics to fight doping
Tue 21 14:30
Symposium 30: Personalised medicine in diabetes and obesity
ENDORSED BY: EJE (European Journal of Endocrinology)
Forum 3
Chairs: Philippe Moulin (France) & Anneke van den Beukel (The Netherlands)
Diabetes, Obesity and Metabolism
Tue 21 14:30
S30.1
Symposium 30: Personalised medicine in diabetes and obesity
Mechanisms for Cardiovascular Complications of Diabetes – Implications for Personalized Therapy
Tue 21 15:00
S30.2
Symposium 30: Personalised medicine in diabetes and obesity
New avenues for novel drugs to treat obesity
Liverpool, United Kingdom
Tue 21 15:30
S30.3
Symposium 30: Personalised medicine in diabetes and obesity
Curing diabetes with alternatives: bariatric surgery
No Session Type 19
Sun 19 12:00
Oral Communications 3: Cushing's and acromegaly
Forum 1
Chairs: Ansgar Heck (Norway) & Marianne Andersen (Denmark)
Sun 19 12:00
OC3.1
Oral Communications 3: Cushing's and acromegaly
Osilodrostat provides clinical benefit over 48 weeks in patients with Cushing disease: Results from the LINC 3 study
Sun 19 12:12
OC3.2
Oral Communications 3: Cushing's and acromegaly
Outcomes after primary treatment for Nelson’s syndrome: a study from 13 UK centres
Birmingham, UK
Sun 19 12:24
OC3.3
Oral Communications 3: Cushing's and acromegaly
Monosynaptic inputs to corticotropin-releasing hormone neuron in hypothalamic paraventricular nucleus of mice at the whole brain scale
Sun 19 12:36
OC3.4
Oral Communications 3: Cushing's and acromegaly
Restoration of basal glucose turnover after disease control in acromegaly depends on treatment modality: a prospective, investigator-initiated trial
Sun 19 12:48
OC3.5
Oral Communications 3: Cushing's and acromegaly
T2-signal intensity, SST receptor expression and first-generation somatostatin analogues efficacy predict hormone and tumor responses to pasireotide in acromegaly
Sun 19 12:00
Oral Communications 4: Thyroid 2
Forum 3
Chairs: Bernard Goichot (France) & James Hennessey (USA)
Sun 19 12:00
OC4.1
Oral Communications 4: Thyroid 2
Subclinical hypothyroidism throughout pregnancy in TPOAb positive pregnant women
Sun 19 12:12
OC4.2
Oral Communications 4: Thyroid 2
Thyroid Dysfunction And Mortality In Cardiovascular Hospitalized Patients – A 12 year Follow-up Observational Study
Sun 19 12:24
OC4.3
Oral Communications 4: Thyroid 2
PROGNOSTIC IMPACT OF MICROSCOPIC EXTRATHYROIDAL EXTENSION (mETE) ON RECURRENCE-FREE SURVIVAL IN PATIENTS WITH PAPILLARY THYROID CARCINOMA (PTC)
Sun 19 12:36
OC4.4
Oral Communications 4: Thyroid 2
Cardiac and vascular characteristics of thyroid hormone resistance syndrome in France
Sun 19 12:48
OC4.5
Oral Communications 4: Thyroid 2
A comprehensive assessment of the interplay between the thyroid function and the immune system: results from the Human Functional Genomics Project
Sun 19 13:45
Industry Sponsored Satellite Symposium
Forum 1
Sun 19 13:45
Industry Sponsored Satellite Symposium
Salle Gratte-Ciel 1+2+3
Sun 19 17:45
Industry Sponsored Satellite Symposium
Forum 2
Sun 19 17:45
Industry Sponsored Satellite Symposium
Salle Gratte-Ciel 1+2+3
Sun 19 19:30
Informal Networking Evening
(Badge holders only)
Mon 20 12:00
Oral Communications 9: Thyroid 1
Auditorium Lumière
Chairs: Clara Alvarez (Spain) & Patrice Rodien (France)
Mon 20 12:00
OC9.1
Oral Communications 9: Thyroid 1
3D mapping and in silico predictions of the DEHAL1 enzyme as a tool to discriminate pathogenic mutations from non-functional variants in hypothyroidism
Mon 20 12:12
OC9.2
Oral Communications 9: Thyroid 1
Direct evidence for disulfides in the mechanism of deiodinase 1
Mon 20 12:24
OC9.3
Oral Communications 9: Thyroid 1
Novel driver mutations in thyroid cancer recurrence
Birmingham, United Kingdom
Mon 20 12:36
OC9.4
Oral Communications 9: Thyroid 1
Resistance to thyroid hormone alpha associated with early-onset severe NASH
Mon 20 12:48
OC9.5
Oral Communications 9: Thyroid 1
Deciphering the origin of the sexually dimorphic thyrotropin secretion in mouse models.
Mon 20 12:00
Oral Communications 5: Adrenal 2
Forum 3
Chairs: Francoise Borson Chazot (France) & Felix Beuschlein (Switzerland)
Mon 20 12:00
OC5.1
Oral Communications 5: Adrenal 2
Positive impact of genetic test on the management and outcome of patients with paraganglioma and/or pheochromocytoma
Mon 20 12:12
OC5.2
Oral Communications 5: Adrenal 2
Pheochromocytoma aggressiveness induced by tumor microenvironment depends on the SDH subunit involved
Mon 20 12:24
OC5.3
Oral Communications 5: Adrenal 2
SF3B1 as novel target for the treatment of multiple endocrine-related cancers
Mon 20 12:36
OC5.4
Oral Communications 5: Adrenal 2
The splicing factor NOVA1 is overexpressed in pancreatic neuroendocrine tumors and related to increased aggressiveness and malignancy
Mon 20 12:48
OC5.5
Oral Communications 5: Adrenal 2
Impact of adrenal insufficiency on patient-centred health care outcomes in adult medical inpatients
Mon 20 12:00
Oral Communications 6: Obesity 1
Forum 2
Chairs: Giles Yeo (UK) & Blandine Gatta-Cherifi (France)
Mon 20 12:00
OC6.1
Oral Communications 6: Obesity 1
Impaired Glucose Homeostasis in Leptin-Deficient ob/ob Mice is Corrected by AZP-3404, a 9-Amino Acid Peptide Analog Derived from Insulin-Like Growth Factor-Binding Protein 2, a Key Mediator of Leptin Action
Mon 20 12:12
OC6.2
Oral Communications 6: Obesity 1
Deep Transcranial Magnetic Stimulation modulates body temperature in obesity
Mon 20 12:24
OC6.3
Oral Communications 6: Obesity 1
Role of hypothalamic bile acid-TGR5 signaling in the regulation of energy balance
Mon 20 12:36
OC6.4
Oral Communications 6: Obesity 1
Fat mass impact of Sirolimus after clinical islet transplantation, a case control study
Mon 20 12:48
OC6.5
Oral Communications 6: Obesity 1
Lipolysis Defect in White Adipose Tissue and Rapid Weight Regaining
Mon 20 12:00
Oral Communications 7: Endocrine Connections
Salle Gratte-Ciel 1+2+3
Chairs: Corin Badiu (Romania) & Marie-Christine Vantyghem (France)
Mon 20 12:00
OC7.1
Oral Communications 7: Endocrine Connections
Cortisol suppression or peripheral sensitivity and activation are associated with diabetes, hypertension and fragility fractures in postmenopausal eucortisolemic women
Mon 20 12:12
OC7.2
Oral Communications 7: Endocrine Connections
Thyroid hormones are new key regulators of glucocorticoid metabolism
Mon 20 12:24
OC7.3
Oral Communications 7: Endocrine Connections
HIGHER DOSE OF BUROSUMAB IS NEEDED FOR TREATMENT OF CHILDREN WITH SEVER FORMS OF X-LINKED HYPOPHOSPHATEMIA
Mon 20 12:36
OC7.4
Oral Communications 7: Endocrine Connections
Non-invasive detection of GNAS mutations causing McCune-Albright Syndrome with ddPCR on whole blood or circulating DNA.
Mon 20 12:48
OC7.5
Oral Communications 7: Endocrine Connections
Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) syndrome : French prospective study in a cohort of 25 patients
Mon 20 13:00
Endo-ERN Session - Lunch Hub
ECE Hub
Mon 20 13:00
ERN1.1
Endo-ERN Session - Lunch Hub
Introduction and update on Endo-ERN
Mon 20 13:01
ERN1.2
Endo-ERN Session - Lunch Hub
Core activities of Endo-ERN in close collaboration with ESE and ESPE: the multi-disciplinary approach
Mon 20 13:02
ERN1.3
Endo-ERN Session - Lunch Hub
Core activities of Endo-ERN in close collaboration with ESE and ESPE: the multi-disciplinary approach
Mon 20 13:45
Industry Sponsored Satellite Symposium
Forum 3
Mon 20 13:45
Industry Sponsored Satellite Symposium
Auditorium Lumière
Tue 21 11:30
Oral Communications 11: Diabetes 2
Auditorium Lumière
Chairs: Philippe Moulin (France) & Colin Duncan (UK)
Tue 21 11:30
OC11.1
Oral Communications 11: Diabetes 2
Hormonal factors and type 2 diabetes risk in women: a 22 year follow-up study on more than 83 000 women from the E3N cohort study
Tue 21 11:42
OC11.2
Oral Communications 11: Diabetes 2
Molecular Mechanisms Regulating Hepatic Sex Hormone-Binding Globulin Production. Clinical Implications in Human Diseases.
Tue 21 11:54
OC11.3
Oral Communications 11: Diabetes 2
Implications of circulating Meteorin-like (Metrnl) level in human subjects with type 2 diabetes
Tue 21 12:06
OC11.4
Oral Communications 11: Diabetes 2
MiR-30e-5p expression is downregulated in plasma and urine of type 1 diabetic patients with diabetic kidney disease
Tue 21 12:18
OC11.5
Oral Communications 11: Diabetes 2
Bone metabolism and circulating myeloid calcifying cells in diabetic post menopausal women: a case-control study
Tue 21 11:30
Oral Communications 12: Endocrine Connections 2
Salle Gratte-Ciel 1+2+3
Chairs: Patric Delhanty (The Netherlands) & Paolo Beck-Peccoz (Italy)
Tue 21 11:30
OC12.1
Oral Communications 12: Endocrine Connections 2
Weekly shifts in light-dark cycle disrupt circadian clock gene expression in bone and reduce bone turnover
Tue 21 11:42
OC12.2
Oral Communications 12: Endocrine Connections 2
Epigenetic Programming of Transgenerational Hypertension in Preterm Birth Mice
Tue 21 11:54
OC12.3
Oral Communications 12: Endocrine Connections 2
Neuronostatin and GPR107 system: a novel therapeutic circuit in Prostate Cancer.
Tue 21 12:06
OC12.4
Oral Communications 12: Endocrine Connections 2
Long-term follow-up of antitumoral immunotherapy- induced hypophysitis in Lille hospital, France
Tue 21 12:18
OC12.5
Oral Communications 12: Endocrine Connections 2
Sexual desire in transgender persons in relation with gender affirming hormone treatment. Results from ENIGI, a large multicenter prospective cohort study in transgender people
Tue 21 11:30
Oral Communcations 13: Anteria and posteria pituitary
Forum 1
Chairs: Mirjam Christ-Crain (Sweden) & Charlotte Højby (Sweden)
Tue 21 11:30
OC13.1
Oral Communcations 13: Anteria and posteria pituitary
Arginine-stimulated Copeptin Measurements - A new Test for Diabetes Insipidus
Tue 21 11:42
OC13.2
Oral Communcations 13: Anteria and posteria pituitary
Empagliflozin increases sodium-levels in patients with the syndrome of inappropriate antidiuretic hormone secretion – a randomized, double-blind, placebo-controlled trial
Tue 21 11:54
OC13.3
Oral Communcations 13: Anteria and posteria pituitary
Pituitary tumour-derived chemokines modulate immune cell infiltrates in the tumour microenvironment leading to aggressive phenotype
Tue 21 12:06
OC13.4
Oral Communcations 13: Anteria and posteria pituitary
Pharmacokinetics of somapacitan in individuals with hepatic impairment: an open-label, parallel group, phase 1 study
Tue 21 12:18
OC13.5
Oral Communcations 13: Anteria and posteria pituitary
Pan-genomic classification of Pituitary Adenomas
Tue 21 11:30
Oral Communications 14: Sex Hormones
Salon Prestige Gratte-Ciel
Chairs: Ilpo Huhtaniemi (Finland) & Michel Pugeat (France)
Tue 21 11:30
OC14.1
Oral Communications 14: Sex Hormones
Testosterone replacement therapy is able to reduce prostate inflammation in men with BPH, metabolic syndrome and hypogonadism: preliminary results from a randomized placebo-controlled clinical trial
Tue 21 11:42
OC14.2
Oral Communications 14: Sex Hormones
The effect of testosterone therapy on serum oestradiol levels in transgender men
Tue 21 11:54
OC14.3
Oral Communications 14: Sex Hormones
First identification of Bone Morphogenic Protein Receptor variants as a cause of Primary Ovarian Insufficiency
Tue 21 12:06
OC14.4
Oral Communications 14: Sex Hormones
Thyroid diseases in Danish women with polycystic ovary syndrome.
Tue 21 12:18
OC14.5
Oral Communications 14: Sex Hormones
The pattern of cancer occurrence in Turner syndrome
Tue 21 13:00
EU research funding - overview of opportunities and insights towards a successful application
ECE HUB - Exhibition area
Chairs: Felix Beuschlein (Switzerland) & Valerie Handweiler (France)
Hub 1.6

0 result(s) found.

Please wait...

     
      - 
     
     
     


    Abstracts from this event
      Abstracts from other events


          Session starts at:
          Abstract time:
        Event:


        Read full abstract